Next Article in Journal
Comparison of Drying Shrinkage of Concrete Specimens Recycled Heavyweight Waste Glass and Steel Slag as Aggregate
Next Article in Special Issue
Design of 3D Additively Manufactured Hybrid Structures for Cranioplasty
Previous Article in Journal
Bottom Contact Metal Oxide Interface Modification Improving the Efficiency of Organic Light Emitting Diodes
Previous Article in Special Issue
Turning Tissue Waste into High-Performance Microfiber Filters for Oily Wastewater Treatment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Advances in Biodegradable 3D Printed Scaffolds with Carbon-Based Nanomaterials for Bone Regeneration

by
Sara Lopez de Armentia
1,
Juan Carlos del Real
1,
Eva Paz
1,* and
Nicholas Dunne
2,3,4,5,6,7,8,9,*
1
Institute for Research in Technology/Mechanical Engineering Dept., Universidad Pontificia Comillas, Alberto Aguilera 25, 28015 Madrid, Spain
2
Centre for Medical Engineering Research, School of Mechanical and Manufacturing Engineering, Dublin City University, Stokes Building, Collins Avenue, Dublin 9, Ireland
3
School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland
4
School of Pharmacy, Queen’s University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK
5
Department of Mechanical and Manufacturing Engineering, School of Engineering, Trinity College Dublin, Dublin 2, Ireland
6
Advanced Manufacturing Research Centre (I-Form), School of Mechanical and Manufacturing Engineering, Dublin City University, Glasnevin, Dublin 9, Ireland
7
Advanced Materials and Bioengineering Research Centre (AMBER), Trinity College Dublin, Dublin 2, Ireland
8
Advanced Processing Technology Research Centre, Dublin City University, Dublin 9, Ireland
9
Trinity Centre for Biomedical Engineering, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland
*
Authors to whom correspondence should be addressed.
Materials 2020, 13(22), 5083; https://doi.org/10.3390/ma13225083
Submission received: 15 October 2020 / Revised: 5 November 2020 / Accepted: 9 November 2020 / Published: 11 November 2020

Abstract

:
Bone possesses an inherent capacity to fix itself. However, when a defect larger than a critical size appears, external solutions must be applied. Traditionally, an autograft has been the most used solution in these situations. However, it presents some issues such as donor-site morbidity. In this context, porous biodegradable scaffolds have emerged as an interesting solution. They act as external support for cell growth and degrade when the defect is repaired. For an adequate performance, these scaffolds must meet specific requirements: biocompatibility, interconnected porosity, mechanical properties and biodegradability. To obtain the required porosity, many methods have conventionally been used (e.g., electrospinning, freeze-drying and salt-leaching). However, from the development of additive manufacturing methods a promising solution for this application has been proposed since such methods allow the complete customisation and control of scaffold geometry and porosity. Furthermore, carbon-based nanomaterials present the potential to impart osteoconductivity and antimicrobial properties and reinforce the matrix from a mechanical perspective. These properties make them ideal for use as nanomaterials to improve the properties and performance of scaffolds for bone tissue engineering. This work explores the potential research opportunities and challenges of 3D printed biodegradable composite-based scaffolds containing carbon-based nanomaterials for bone tissue engineering applications.

1. Bone Defect Healing

1.1. Natural Process of Bone Healing

Bone is composed of a mineralised organic matrix and cells. The matrix provides the bone with its mechanical properties and is comprised of organic and inorganic phases. In the organic phase, type I collagen is the major component and it is responsible for the tensile properties of the bone. Conversely, the inorganic phase comprises hydroxyapatite, which is responsible for exhibiting the compressive properties and for providing the building blocks for new bone formation. Cells are embedded in the matrix, which includes osteoblasts, osteoclasts, osteoprogenitor cells and mature osteocytes [1].
Bone fractures and segmental bone defects are often caused by traumatic injury, cancer or other diseases (e.g., osteoporosis or arthritis) [2]. When a defect appears, the spontaneous fracture healing process begins through two different mechanisms, depending on the mechanical environment. If the strain across the fracture site is less than 2%, primary or direct healing by internal remodeling occurs, whilst secondary or indirect healing by callus formation takes place when strain is between 2 and 10%. The latter type of healing is the process that most fractures follow and it depends on osteogenesis, osteoinductivity and osteoconductivity [3].
However, sometimes bones defect cannot heal spontaneously. This situation occurs especially in large segmental bone defects when the defect reaches a critical size [4]. The precise critical size depends on several factors (i.e., anatomic location, age of the patient, soft tissue environment); in the literature, it is suggested to include defect lengths greater than 1–2 cm and greater than 50% loss of the circumference of the bone [5]. In these cases, additional surgical interventions that help and allow bone healing are required. The available healing processes depending on the size defect are summarized in Figure 1.

1.2. Conventional Surgical Solutions

Among the conventional surgical solutions, it is important to highlight bone grafting, distraction osteogenesis and induced membrane techniques [4].
Autologous [6], allograft [7] and synthetic bone grafting [8] are extensively used for repairing bone defects. More specifically, autograft represents the gold standard for the treatment of critical-sized bone defects since it contains all the characteristics for new bone growth (osteoconductivity, osteogenicity and osteoinductivity). However, significant problems are associated with its use, from donor-site morbidity to a limited amount of donor bone [9,10,11]. Other associated issues, such as failed anastomosis, microvascular thrombosis and infection or progressive deformities, have also been reported [12,13].
Another technique extensively studied since the 1950s is distraction osteogenesis. Ilizarov successfully treated his first patient in 1954, reducing the healing time of tibial non-union [14]. This method is based on the capacity of regeneration under tension that the bone presents naturally. Despite the good results that the Ilizarov technique present [15,16], it also has some disadvantages, such as prolonged treatment times, pin site infection [17,18], pin breakage and the inconvenience and burden of prolonged external fixation, which includes muscle contractures, joint luxation and axial deviation [19,20,21,22].
Finally, the induced membrane technique is a two-stage procedure that combines the use of a temporary poly(methyl methacrylate) (PMMA) cement spacer, followed by bone grafting [23]. In 2000, the first cases using the induced membrane technique were reported [24]. Generally, this technique achieves its purpose; however, some complications have been reported. The most common complications include infection, amputation, malunion, fracture and reoperation and additional bone grafting due to non-union [24,25,26].

1.3. Scaffolds for Bone Regeneration

To avoid problems encountered when using conventional methods, the field of bone tissue engineering was developed in the early 1980s [27]. Researchers working in the field of bone tissue engineering have made an important effort for developing 3D porous matrices, known as scaffolds. They are based on guided bone regeneration, the aim of which is bone regeneration and growth along the surface of the scaffold [28].
Scaffolds act as a temporary matrix for the attachment, viability and growth of cells whilst maintaining the structure of the regenerated bone in vivo [29]. The main advantage of bone tissue engineering is the potential elimination of donor scarcity, pathogen transfer and immune rejection [30].
Ideally, to properly promote bone regeneration, scaffolds should meet specific requirements [29,31,32]:
(1)
The material and its degradative by-products should be biocompatible and not evoke inflammation or toxicity when implanted in vivo.
(2)
Three-dimensional structures should be manufactured in a reproducible manner.
(3)
High surface area is needed for cell–polymer interactions, extracellular matrix regeneration and minimal diffusion constraints. It is achieved with a porosity of at least 90% and pore size of at least 100 μm [29]. Furthermore, it should have an interconnected porous structure, with a pore size suitable to allow cell adhesion, growth, vascularisation of the tissue and transportation of nutrients.
(4)
Scaffolds should be capable of being resorbed once their function of providing a template for regenerating bone has completed. Permanent foreign materials inside the body could lead to a permanent risk of inflammation.
(5)
The degradation or the resorption rate and the rate of bone formation should be similar. For this reason, the degradation rate of the scaffold should have the potential to be adjustable depending on the cell type.
(6)
Scaffolds should also demonstrate mechanical properties similar to bone.
It is important to highlight that porosity and mechanical properties have an inverse relation. For this reason, a compromise must be found between these characteristics.

1.4. Limitation of Bone Tissue-Engineered Scaffolds

Despite the great research advancements in the design, manufacture and application of bone tissue-engineered scaffolds for bone repair and replacement, there still are some drawbacks and challenges that need to be addressed. The main drawbacks of synthetic scaffolds are: poor biodegradability, potential toxic degradation of by-products, poor osteoconductivity, poor mechanical properties, uncontrolled porosity or complicated reproducibility [33].

2. Nanomaterials for Scaffolds

2.1. Why Are Nanomaterials a Potential Solution?

The use of nanocomposite biomaterials in bone tissue engineering has emerged to improve the mechanical properties as well as physicochemical properties of the polymeric matrix, such as mechanical strength and Young’s modulus, hydrophilicity or biological response (e.g., cell adhesion, proliferation and differentiation, biocompatibility and antimicrobial effect). Nanocomposites for biomedical applications normally have two phases: a biocompatible matrix and a nanosized bioactive/resorbable filler [34,35,36]. One of the main advantages of nanomaterials is their large surface area, which results in a large volume fraction of interfacial material (even at low loadings).
In general, by controlling the volume fraction, arrangement and morphology of the filler phase within the matrix, it is possible to tailor the physicochemical and mechanical properties and the response to the host tissue [27]. In this section, some of the most interesting data relating to the application of nanocomposites in bone tissue engineering will be reported; the application of carbon-based nanomaterials will especially be considered.

2.2. Ceramic Nanomaterials

Ceramic nanomaterials, such as calcium phosphates or calcium silicates, may improve the biological response by releasing calcium and phosphate ions that are essential for bone growth. However, a detrimental effect on the mechanical properties has been reported when the amount of inorganic particles is high [37].
The most commonly used ceramic-based nanomaterial is nanohydroxyapatite (nHA). It demonstrates excellent biocompatibility and low toxicity. Several matrices have been filled with nHA (thermoplastic polyurethane (TPU)/polydimethylsiloxane (PDMS), poly ε-caprolactone (PCL), polylactic acid (PLA), etc.) and, in all cases, it has been observed that by comparing the nanocomposite with the pristine matrix, they show a reduction in hydrophobicity, as well as an increase in cell proliferation, mineralisation and differentiation [38,39,40,41].
Calcium phosphate nanoparticles have proved to improve mechanical resistance and the attachment and proliferation of osteoblasts and can demonstrate an antibacterial effect [42,43].
Other ceramics, such as nanosized aluminium oxide [44], titanium oxide [45] or silica [46], have been shown to augment different properties that make them very interesting as potential nanomaterials for bone tissue engineering applications.

2.3. Metallic Nanomaterials

In general, metallic nanomaterials are interesting in bone tissue engineering due to the antimicrobial and bactericidal activity that some of them demonstrate.
Silver nanoparticles are well-known for their antimicrobial activity against a broad spectrum of infectious agents [47]. Specifically, silver ions present a marked antibacterial effect since they cause a disruption of bacteria cell membranes and inhibit enzymatic activities and DNA replication [48]. In the same way, copper and bronze also present bactericidal nature [49].
Gold nanoparticles have also been used to create a polymer nanocomposite due to their inherent low toxicity and antiseptic and antibacterial activity, which prevent bacterial growth in the surgical wound [50,51].
Other metal ions, such as strontium or copper, have been widely used to dope bioactive glasses, improving their osteogenesis, angiogenesis and antibacterial activity [52,53].
Another interesting metal extensively used in bone tissue engineering is magnesium. It presents high mechanical properties, specific strength and elastic modulus, and has a good biodegradability and biocompatibility. However, its high degradation rate limits its application as a matrix material, but the presence of magnesium as a nanomaterial induces osteogenic differentiation [54,55].

2.4. Polymer Nanomaterials

Polymers are not used as nanomaterials in bone tissue engineering, but as a coating for other nanomaterials or to enable modification of the matrix. For instance, poly(acrylic acid) or poly(methacrylic acid) grafted to carbon nanotubes improves the potential for cell differentiation of scaffolds [56,57].
In the case of polymers added to the matrix, there are two different paths: co-polymers, formed by two or more monomeric species, and polymer–polymer blends, which involve a mixture of two polymers [27]. Among the co-polymers used in bone tissue engineering, poly(lactic-co-glycolic acid) (PLGA) [58,59] and poly(lactide-co-caprolactone) [60,61] are the most commonly used. Conversely, in the field of polymer blends, many studies are found on gelatin-polyvinyl pyrrolidone [62], gelatin-poly(lactide acid) [63], cellulose acetate-polycaprolactone [64], polyurethane/poly(lactic acid) [65], poly(lactide acid)/polycaprolactone [66,67], etc. Sometimes, they are incorporated into a ceramic matrix to improve their toughness and processability. Both synthetic [68,69] and natural [70] polymers are used for this purpose.

3. Carbon-Based Nanomaterials

Carbon-based nanomaterials have shown a high capability for bone tissue engineering since they present excellent mechanical properties and an intrinsic antibacterial activity [71]. The majority of carbon-based nanomaterials have also been shown to promote cell regeneration and decrease the hydrophobicity of the composite material. The interaction of carbon-based nanomaterials with biological molecules depends on the chemical composition, shape, size, stability, functionalisation, porosity and agglomeration of the nanomaterial. Therefore, it is important to study each carbon-based nanomaterial individually [72]. All their biological advantages will be discussed in detail in the next section.
Due to their geometry, carbon-based nanomaterials present an interesting toughening effect that can follow four different mechanisms (Figure 2): (i) crack bridging—carbon-based nanomaterials delay crack propagation, bridging the two surfaces and provide stress that counteracts the applied stress; (ii) pull-out—carbon-based nanomaterials are pulled out the matrix, slowing down crack propagation by the interfacial friction; (iii) crack deflection—crack cannot continue its path for the presence of carbon-based nanomaterials and it follows a tortuous path with high energy dissipation; (iv) crack tip shielding—the crack does not have enough energy for interface debonding and the crack tip is restricted [73].
Thanks to their biological and mechanical improvements, the addition of carbon-based nanomaterials has the potential to transform relatively inert materials into materials demonstrating appropriate mechanical properties and bioresponsiveness for bone tissue engineering scaffolds.

3.1. Types of Carbon-Based Nanomaterials

The different types of carbon-based nanomaterials are shown in Figure 3, and explained in the following subsections.

3.1.1. Carbon Nanotubes

In 1991, carbon nanotubes (CNTs) were first reported by Iijima [74], when he discovered multiwalled carbon nanotubes (MWCNTs). Later, in 1993, he discovered single-walled carbon nanotubes (SWCNTs) [75].
CNTs present a tubular shape; their structure is akin to rolled-up graphene sheets. SWCNTs’ diameters are typically in the range 1–2 nm, they are generally narrower than MWCNTs, and they tend to be curved rather than straight [76]. In the case of MWCNTs, the outer diameter depends on the number of layers and ranges from 2 to 30 nm. Typically, the length is in the micrometre range but can differ from 1 µm to a few centimetres [77].
CNTs present unique structural, electrical, mechanical, electromechanical and chemical properties, and as a consequence their application in regenerative medicine has been widely investigated [78].
For example, the addition of MWCNTs to PLA demonstrated an improvement in osteoblast growth [79] due to their excellent electrical properties, since the electrical stimulation may modify cellular activities such as cell adhesion or cell migration [80,81].
Several studies have demonstrated that MWCNTs can promote stem cell differentiation towards bone cells and enhance bone formation. Furthermore, they act as a mode of reinforcement for mechanical strengthening and biocompatibility [56,82,83,84,85], improving the performance of different biomaterials. The case of SWCNTs is very similar, and it has been proved that SWCNTs can be incorporated into some biodegradable polymers that present problems due to their poor mechanical properties to successfully reinforce them [86], without adversely affecting the biocompatibility of the matrix [87].

3.1.2. Graphene Derivatives

Graphene

Since its discovery in 2007 [88], the application of graphene (G) has experienced a significant rise. Graphene is a two-dimensional carbon material, one atom thick. Its atomic structure is a honeycomb lattice of carbon atoms and is the basic building block for graphitic materials. It presents a very high surface area (32.216 m2·g−1), higher than SWCNTs, excellent thermal conductivity (3000–5000 W·m−1·K−1), mechanical properties (42 N·m−1 of break strength, 130.5 GPa of intrinsic tensile strength with Young’s modulus of 1 TPa) and electrical conductivity (5.9 × 105 S·m−1) [89,90,91,92].
Since it presents high electrical conductivity, G is used to manufacture electro-active scaffolds. The addition of G stimulates cell proliferation and decreases the immune response [93]. Graphene has also been shown to improve the mechanical properties of biomaterials without compromising biocompatibility [94].

Graphene Oxide

Graphene oxide (GO) is produced by oxidising graphite in acidic medium, increasing the hydrophilicity of the surface and creating functional groups (i.e., hydroxyl, epoxy, carboxyl, carbonyl, phenol, lactone and quinone) [95]. It can modulate their characteristics with the degree of oxidation. Graphene oxide is an electrical insulating material because it has disrupted sp2 bonding networks due to the presence of functional groups. Their mechanical properties are excellent, but they do not reach the values of G (28–47 GPa of intrinsic strength, with a Young’s modulus of 380–470 GPa) [96,97].
Oxygen functional groups present in the GO structure can experience strong hydrogen bonding interactions with the polymer matrix, improving the interfacial adhesion between them and, therefore, the mechanical properties of nanocomposites [98].
Recent studies have demonstrated that GO promotes cell regeneration, which makes it an interesting material for its application in regenerative medicine. For example, GO has been used to induce piezoelectric behaviour that promotes cell proliferation by generating electrical stimulation [99].
Many studies have reported the use of reduced graphene oxide (rGO) instead of GO in the preparation of nanocomposites [70,100,101]. The reduction in GO leads to the elimination of most oxygen-containing functional groups, thus the sp2 structure and, therefore, electrical conductivity are partially restored; consequently, rGO reaches excellent electrical conductivity and high mobility [96,102,103].

Graphene Nanoplatelets

Graphene nanoplatelets (GNPs) show a structure similar to idealised G, but in comparison, their production is much more cost-effective. They consist of small stacks of G nanosheets, such as the structure found on MWCNTs, but with platelet shapes. GNPs may be functionalised with different chemical entities, such as carboxyl graphene nanoplatelets [104] or GO nanoplatelets [105].
In the case of carboxyl GNPs, they offer good reinforcement from a mechanical point of view and, due to their large surface area, surface roughness and high protein adsorption, they favour osteoblast cell attachment, proliferation and differentiation [104].

3.1.3. Fullerenes

In 1985, Kroto et al. discovered fullerene [106], the third carbon allotrope, after graphite and diamond. Fullerene presents a structure consisting of sp2 carbons in a high symmetric cage. Carbon forms pentagons and hexagons packed in a spherical shape [107].
Fullerenes have been used to reinforce polymers with poor mechanical properties. However, ultrashort carbon nanotubes present better results in terms of mechanical reinforcement [108].

3.1.4. Carbon Dots

Carbon dots are zero-dimensional nanomaterials that are formed by 2–3-parallel graphene sheets. Carbon dots consist of a carbogenic core with oxygen, hydrogen and carbon on their surface. They present an excellent solubility in water, biocompatibility, optical properties, chemical inertness and neglectable toxicity [109,110].
Some research works suggest that carbon dots do not affect cell viability, proliferation, metabolism and differentiation [111]. They are not extensively used in the fabrication of bone tissue-engineered scaffolds [112]. However, for other biomedical applications, such as drug/gene delivery, bioimaging or photothermal and photodynamic therapy, they have been extensively studied [110,113].

3.1.5. Nanodiamond

Carbon atoms in diamond exhibit sp3 hybridisation. Four bonds are directed towards the corners of a regular tetrahedron. Diamond is extremely hard due to the rigidity of the three-dimensional network [76]. Nanodiamonds (NDs) were discovered in 1963–1982 [107].
When added to a polymeric matrix, NDs act as a cell growth support and improve the chemical stability and the biocompatibility of the nanocomposite [114,115,116].

3.2. Carbon-Based Nanomaterials for Bone Regeneration

Carbon-based nanomaterials are promising candidates for bone repair and regeneration applications due to the exceptional combination of excellent mechanical, thermal and electrical properties along with their proven antimicrobial and cell regeneration capabilities.
In general, carbon-based nanomaterials demonstrate antimicrobial activity. The cellular membrane integrity, metabolic processes and morphology of the microorganisms are affected by the direct contact with carbon nanostructures [118].
The size and surface area of the carbon-based nanomaterials play an important role in the inactivation of microorganisms. The smaller the carbon-based nanomaterial, the higher the surface area, which results in an improvement in its interaction with bacteria [119]. Among carbon nanostructures, fullerenes, SWCNTs and GO and their derivatives have been reported to be the most efficient antibacterial agents [118].
Conversely, nanocomposites with carbon nanomaterials favour cell adhesion and proliferation on their surface and encourage bone growth. It is suggested that this bone regeneration capability is due to different effects—e.g., the increase in surface roughness or the improvement of the hydrophilicity because of the presence of carbon-based nanomaterials. It was also reported that carbon-based nanomaterials present an increase in the protein absorption capability due to their large surface area and ability to interact with proteins [120].
Besides, most of the carbon-based nanomaterials exhibit high electrical conductivity, which opens an interesting avenue of discovery for bone tissue-engineered scaffolds, since it has been reported that electrical stimulation induces osteogenesis and stimulates bone repair. This electrical stimulation has already been used for bone consolidation, incorporation of grafts and treatment of osteoporosis [121,122,123,124,125,126].

3.2.1. Antimicrobial Activity

Contrary to bulk materials, nanomaterials have the capacity to cross cell membranes easily, leading to the destructive effect on the bacteria cell [127]. There are four main bactericidal mechanisms of antimicrobial nanomaterials and carbon-based nanomaterials could promote them:
  • Reactive oxygen species (ROS) generation [128]: cell death is produced by the damage of DNA induced by ROS. These ROS include superoxide anions, hydroxyl radical and hydrogen peroxide.
  • Physical damage [129]: some nanostructured materials present sharp edges that can damage the bacterial cell wall membranes.
  • Binding [130]: loss of cell membrane integrity and efflux of cytoplasmic materials can be caused by binding materials on the bacterial cell wall.
  • Release of metal ions [131]: inhibition of adenosine triphosphate (ATP) production and DNA replication produced by metal ions released into the media may cause the death of cells.
As a consequence of their different characteristics, each type of carbon-based nanomaterial promotes one or several of these mechanisms, acting in different ways.
The antimicrobial activity of CNTs can be related to the formation of cell–CNT aggregates that damage the cell wall of bacteria and release their DNA content [132].
Compared to MWCNTs, SWCNTs present more potent antimicrobial activity. Due to their smaller nanotube diameter, they could have tight contact and penetrate easily in the cell wall. Besides, their higher surface area allows SWCNTs to interact better with the cell surface [118].
Antimicrobial activity is also affected by the length of the SWCNT. It is reported that the longer the CNT, the higher the antimicrobial activity. It is explained by the interactions between cells and the SWCNT; the shorter SWCNT is more likely to be self-aggregated without involving lots of bacterial cells [133].
Conversely, the main antimicrobial mechanism of graphene-related nanomaterials is membrane stress provoked by the direct contact with sharp nanosheets after the cell deposition on graphene-based materials [134].
Furthermore, GO can damage cell membranes via generation of ROS. Thus, the antibacterial mechanism of GO is affected by both physical destruction and chemical oxidation, which results in a decrease in bacterial resistance [135].
In the case of fullerenes, their antimicrobial activity could follow three different mechanisms: (i) internalisation of the fullerenes into the bacteria, which inhibits the energy metabolism, (ii) the impairing of the respiratory chain inhibits bacterial growth and (iii) the induction of cell membrane disruption [118,136]. The hydrophobic surface of fullerenes promotes the interaction with membrane lipids and the intercalation between them [136].
Alternatively, NDs present antibacterial activity since they can form a covalent bond with molecules on cell walls or adhere to intracellular components. This process inhibits vital enzymes and proteins, leading to a rapid collapse of the bacterial metabolism and finally cell death [137].
Accordingly, the use of carbon-based materials to improve the antimicrobial capacity of biomaterials is very interesting and, therefore, their use in the manufacturing of scaffolds may bring great improvements.

3.2.2. Osteoconductivity

First of all, it is important to establish the difference between osteoinductivity and osteoconductivity. Osteoinduction is the process by which osteogenesis is induced—i.e., primitive, undifferentiated and pluripotent cells are stimulated to develop into preosteoblasts. Conversely, osteoconductivity is the capacity of a material to allow bone growth on its surface or down into pores, channels or pipes [138].
CNTs demonstrate osteoconductivity and they can provide a favourable extracellular matrix for cell adhesion due to their similar dimensions to natural collagen fibres. Their osteoconductivity may also be explained by electrochemical interactions between CNTs and cells and by an increase in hydrophilicity [126,139,140].
When graphene-related nanomaterials, especially G and GO, are added to a polymer matrix, it is found that they increase cell adhesion and proliferation by increasing hydrophilicity [141,142,143]. It is reported [144] that this effect is higher in GO, which increases hydrophilicity and leads to better cell behaviour.
However, to achieve osteoinductivity, it is necessary to add some functionalisation to the GO surface, by using, for example, poly(ethylamine) [141], poly(lactide-co-glycolide acid) [145], collagen [146], phosphates [147], hydroxyapatite [148] and silanes [149].
In general, carbon nanomaterials present osteoconductivity, but they are not osteoinductive. However, a recent study [150] has reported that low oxygen content graphene nanoparticles may favour the adhesion of cells and they can undergo osteogenesis on the surface of these nanocomposites.
The case of fullerenes is completely different; fullerene-based films present a decrease in the adhesion of cells with less spreading, growth, metabolic activity and viability. This is explained because fullerene presents an electron-deficiency structure, which is responsible for its high chemical reactivity. For presenting osteoconductivity, fullerene films need to be aged for one year. In that moment, due to fragmentation, oxidation and polymerisation, fullerene supports cell colonisation well [151,152].
Finally, ND incorporation leads to an increase in cell growth on the polymer. As in the case of graphene-related nanomaterials, some studies demonstrated that the wettability is increased with the addition of NDs due to the oxygen termination of the diamond nanoparticles [153,154].

3.3. Limitations and Toxicity

In general, carbon-based nanomaterials present inconclusive results when studying their cytotoxicity. The reason is because their toxicity depends on many factors, such as the shape, size, purity, post-production processing steps, oxidative state, functional groups, dispersion state, synthesis methods, route and dose of administration and exposure times [94,155,156]. This makes it very difficult to obtain general conclusions which could be extrapolated to all cases.
Related to the cytotoxicity of CNTs, once implanted in the body, MWCNTs are thought to be biopersistent [157] and could interfere in different physiological processes. For example, in vivo studies reported that the presence of MWCNT agglomerates led to the attachment of multinucleated cells. On its part, SWCNTs were transported from the site of implantation to the lymph nodes and potentially block potassium channel activities in mammalian cell systems. It was also found that the needle-like shape of CNTs promoted the mobility and the penetration of membranes, uptake by cells and strong interactions with various protein systems. These findings may suggest undesirable effects relating to cytotoxicity [158,159,160].
Another problem that can be found in the application of CNTs is that the metal catalysts used in their fabrication are generally trapped inside the nanotubes, which can lead to an increase in cytotoxicity [161].
However, in contrast to these findings, other studies have reported no cytotoxicity effects when CNTs were incorporated into matrix-based materials for bone tissue-engineered scaffolds [162,163,164,165].
Concerning graphene-related materials, the inconsistencies reported from other studies are similar to the studies using CNTs. When they are used as a substrate or coating, some research studies [166,167,168] found that G presented good biocompatibility and the ability to stimulate cell proliferation. Other studies [160,169] reported some cytotoxicity risks since G presented an important tendency to form an agglomerate. When G sheet agglomeration occurs on the cell membrane, it can contribute to their toxic properties. Besides, at high concentrations and long exposure times, ROS were generated by G.
In the case of nanocomposites, contradicting evidence has also been reported when G and GO are incorporated into a matrix. Luo et al. [144] found that the addition of G had a negative impact on cell adhesion, whilst GO presented a positive effect. Türk et al. [170] also found cytotoxicity when G was introduced into a matrix composed of Bioglass. However, several studies [93,143] reported no cytotoxicity when G was introduced in scaffolds (Figure 4 and Figure 5).
In the case of GO, it was found that its presence may reduce the cell proliferation rate due to an increase in the intracellular ROS level [171]. However, other studies [172,173,174,175,176] found that neither GO nor rGO presented cytotoxic effects at low concentrations.
Fullerenes also present contradicting results. On one hand, it was found that fullerene nanoparticles induced DNA breakage [177] and oxidative damage to cellular membranes due to ROS generation [178,179]. However, other studies [180] demonstrated no cytotoxic effect on fullerenes.
In the case of NDs, many studies concluded that no cytotoxicity had been found [181,182,183]. In an extensive study, no ROS generation was found. However, it was found that NDs could easily access the cell membrane, but they seemed to be non-reactive once inside the cell [184].
All these contradicting results make in vitro and in vivo studies crucial for the development and the complete understanding of nanocomposites with carbon-based materials. However, and despite the contradictions found, in most cases, the biocompatibility of carbon-based nanomaterials was found and cytotoxicity was reduced when carbon-based nanomaterials were used as reinforcements embedded inside a matrix.
The area that needs further investigation relates to biodegradable matrices that release carbon-based nanomaterials during their degradation process. Carbon-based nanomaterials were assumed to be biopersistent; however, oxidative enzymes can catalyse the degradation of some carbon-based nanomaterials (e.g., GO or CNTs) [185]. Furthermore, carbon-based nanomaterials may affect the degradation rate of the matrix and the toxicity of the degradation products. To the best of the authors’ knowledge, there are not many research studies relating to this approach.
Sánchez-González et al. [186] found that the addition of rGO caused a slight acceleration in the hydrolytic degradation process, reducing its mechanical stability faster when compared to the pristine polymer. However, rGO was not released to the medium, but it remains embedded in the polymer matrix.
Murray et al. [187] found that when G was added at high levels of loading (5 wt.%), the enzymatic degradation rate was lower than the pristine polymer than the polymer with low levels of G (0.1 and 1 wt.%). They also found that the mechanism by which the G was bonded to the matrix was also affected by the degradation rate. When studying the toxicity of the degradative by-products, it was found that G reduced the toxicity. A decrease in the enzymatic and hydrolytic degradation rate when GO was added was also found. [188,189,190,191]. In the case of enzymatic degradation, the effect of graphene derivatives was due to the presence of sheets that prevented the diffusion of the enzymes into the scaffold network [192].
Finally, Cabral et al. [70] found that neither G nor rGO had a significant effect on the enzymatic degradation rate.
In the case of MWCNTs, Joddar et al. [193] reported a decrease in degradation rate when added to a biodegradable matrix. It may be concluded that the presence of carbon-based nanomaterials incorporated into a matrix reduces the degradation rate and it could be tailored relative to the level of nanomaterial loading.
Table 1 summarizes all the aspects of CBNs regarding their use for bone tissue regeneration.
With these contradictions in mind, it would be interesting to apply concepts to reduce the uncertainties and risks of human and environmental safety surrounding nanotechnology, which have been proposed as an interesting approach during the design of polymeric nanocomposites for biomedical applications. Safe-by-Design (SbD) concepts foresee the risk identification and reduction in early stages of product development. The main elements of the general SbD approach are: (1) stage-gate innovation approach; (2) three pillars—safe materials and products, safe production and safe use and end-of-life; (3) including SbD action for maximizing safety while maintaining functionality and (4) integration into a Safe Innovation Approach [194].

4. Additive Manufacturing of Bone Tissue-Engineered Scaffolds

Both material and manufacturing technology affect the final performance of scaffolds. Regarding the manufacturing technology, additive manufacturing has lately been explored and the first results are very promising.

4.1. Importance of Porosity and Geometry

The fabrication of bone tissue-engineered scaffolds is associated with the production of controlled porous and interconnected structures since porosity and interconnectivity are two of the requirements needed for achieving adequate bone repair and regeneration. The porosity is important for cell adhesion, growth, revascularisation and adequate nutrition. Kuboki et al. [195] found that solid particles did not promote the formation of new bone, while for porous particles of the same material, osteogenesis occurred. Regarding interconnectivity, Conrad et al. [196] found that interconnectivity increases permeability and, therefore, improves cell infiltration and bone ingrowth.
The size of pores is critical; if pores are not large enough, cell migration is limited, and they may remain at the edges of the scaffold, thereby forming a cellular capsule. Minimum pore size is approximately 100 μm, due to cell size, migration requirements and transport [197]. Conversely, if the pore size is too large, then the surface area decreases and consequently cell adhesion is limited. The results from the study by Murphy et al. [198] corroborate this fact (Figure 6). In extreme cases, for pores that were relatively large or small in size, cell proliferation was not promoted—the cell number remained constant or even decreased. However, intermediate pore sizes promoted cell proliferation over time. Besides, the number of cells was not proportional to the pore size.
Furthermore, pores within a bone tissue-engineered scaffold must be interconnected since this interconnectivity, as well as the pore structure and overall porosity, is fundamental in determining the osteogenic capability of a bone tissue-engineered scaffold [199,200].
Regarding scaffolds’ geometry, there are studies [201,202] that prove how geometry plays an important role in cells response. The geometry may induce stem cells to differentiate towards specific lineage.
Both pore distribution and geometry of scaffolds are decisive in cell penetration, proliferation and differentiation as well as in the rate of scaffold degradation, which must be in accordance with the maturation and regeneration of new tissue.

4.2. Additive Manufacturing

To have the appropriate pore size distribution and interconnectivity, different approaches to fabricate porous scaffolds have been studied: salt-leaching [203,204,205], gas foaming [206,207], electrospinning [208,209,210] and freeze-drying [211,212]. However, with these fabrication methods, it is possible to produce bone tissue-engineered scaffolds without controlling pore size distribution and shape, porosity and interconnectivity.
In general, traditional methods present limitations related to the control of overall pore architecture and interconnectivity and bone tissue-engineered scaffolds produced by these techniques present poor reproducibility and accuracy [213,214].
Additive manufacturing (AM) has emerged as a technology that enables the fabrication of 3D porous scaffolds with a high level of reproducibility and accuracy with minimal human intervention.
One of the main advantages of AM techniques is the possibility to produce customised scaffolds with a reproducible internal morphology and pore architecture control, tailored mechanical and mass transport properties and even produce scaffolds with functionally graded materials [215,216].
According to ISO/ASTM standards [217], AM technologies can be classified into seven different groups: (i) binder jetting, (ii) direct energy deposition, (iii) material extrusion, (iv) material jetting, (v) powder bed fusion, (vi) sheet lamination and (vii) vat photopolymerisation.
Outside this classification, other novel techniques are emerging, as is the case of bioprinting, which combine the use of 3D printing technology with materials that incorporate viable living cells. However, these kind of materials fall outside the scope of this review.
Among all the AM technologies, the focus of this review is on those used to manufacture biodegradable scaffolds (i.e., polymer-based and ceramic-based) that allow the incorporation of nanomaterials, more specifically carbon-based nanomaterials.
Researchers have developed biodegradable polymer scaffolds loaded with carbon-based materials fabricated using different AM techniques: (i) material extrusion (e.g., Fused Deposition Modeling, FDM and Direct Ink Writing, DIW), (ii) powder bed fusion (e.g., Selective Laser Sintering, SLS and Selective Laser Melting, SLM) and (iii) vat photopolymerisation (e.g., Stereolithography, SLA and Digital Light Processing, DLP).
In the case of biodegradable ceramic scaffolds, since they do not melt easily, these scaffolds are fabricated by AM using mainly powder bed fusion (SLS). However, to counteract the natural fragility of ceramics, they are usually blended with polymers. For this reason, sometimes other 3D printing techniques are used, such as DIW [54] or FDM [68].
The advantages and limitations of these technologies are detailed in Table 2. Accuracy defines the minimum pore size that can be obtained with each technology. Methods used in each technology for the dispersion of nanoparticles within the matrix are also indicated in the table; this aspect is especially important because the optimal methods to obtain an adequate dispersion are very different depending on the technology.

4.2.1. Material Extrusion

These technologies are based on the extrusion of the material under pressure. The material is deposited from a nozzle or syringe to fabricate components in a layer-by-layer manner. These technologies require a liquid or a viscous material that is obtained mainly by two methods, melting a thermoplastic material (FDM) or using a viscous ink (DIW) [218].
FDM has shown rapid development in recent years due to its simplicity, speediness and large-scale rate of production. Raw materials in FDM are filaments that are partially melted by a heater and extruded from a nozzle.
In the case of DIW, the material used is colloidal ink which is directly extruded through an orifice or nozzle without heating. These inks can maintain their shapes during solidification or drying.

4.2.2. Powder Bed Fusion

SLS and SLM are categorised as powder bed fusion technologies since they utilise thermal energy to selectively melt powder materials of a powder bed. The raw material is typically in the form of powder-based particles for these AM-based technologies [219]. Complete melting is achieved in SLM, while in SLS heat provokes material fusion at the molecular level instead of complete melting [220].
Thermal energy may be obtained by different sources such as lasers or electron beams. In the case of scaffolds with carbon-based nanomaterials, technologies that obtain energy by laser sources are used.

4.2.3. Vat Photopolimerisation

The SLA technique was developed in the 1980s and was one of the first methods proposed for 3D printing [221]. The SLA and DLP techniques involve solidifying a liquid photocurable polymer by exposure to UV light. The photopolymer is placed in a tank and it is cured layer-by-layer on a support platform with a light source (250–400 nm).
The difference between the two techniques is the light source: in SLA, the polymer is cured using a laser that forms each layer point-by-point; in DLP, all the layers are cured at the same time using a matrix of lasers.
Components printed using these AM techniques require a post-curing process (usually, UV exposure + temperature) to achieve their final properties. Considering biomedical applications, this could be used to sterilise the components to be implanted into the body, which could be an additional advantage [222].
Some researchers [223,224] have taken advantage of these AM techniques by modifying a non-photocurable polymer in order to make it photocurable, allowing the use of biodegradable and biocompatible polymers appropriate for bone tissue-engineered scaffolds.
The addition of nanomaterials to improve the properties of additive manufactured structures has been widely investigated. It is well known that the dispersion of nanomaterials is crucial for the attainment of unique properties for the composite. For example, the presence of agglomerates reduces the mechanical properties of the composite [99,189]. Consequently, the method of incorporating the nanomaterials into the matrix is very important for the final composite’s performance.
In the case of AM technologies, the dispersion of nanomaterials depends on the characteristics of matrix materials. When they are solid (FDM, SLS and SLM), usually a solvent is used to disperse nanomaterials easily by ultrasonication [225,232] or mechanical mixing [226]. In the case of materials that melt easily, if their viscosity is low enough, melt mixing can be used as a solvent-free alternative [227,231]. Finally, in the case of powder matrix and powder nanomaterials, they can be mixed using a rotary tumbler [233].
Conversely, DIW, SLA and DLP use liquid raw materials. Ultrasonication is the most common method to achieve the optimal dispersion of nanomaterials in liquid-based raw materials [236,238,239,240], although other mechanical mixing methods have also been used [229]. Sometimes, when the viscosity is high, a solvent is added, which promotes dispersion of the nanomaterial [237].

4.3. Biodegradable Materials for 3D Printed Scaffolds

One of the requirements that the materials must meet for being used as tissue-engineered bone scaffolds is biodegradability. Among biodegradable materials that are used with carbon-based nanomaterials, it is possible to distinguish between polymeric and ceramic materials.

4.3.1. Polymer Matrices

Polymeric materials have been widely used for bone tissue engineering applications. They are classified by their origin: (i) natural and (ii) synthetic polymers. Natural polymers include silk fibroin, collagen, gelatin fibrin, elastin, cellulose, alginate, dextran, starch, chitin/chitosan, glycosaminoglycans and hyaluronic acid, among others. Bone scaffolds fabricated using natural polymers by conventional methods have been extensively reported [241,242]. However, the preferred polymers for AM are the synthetic biodegradable ones, and can be classified as follows [243,244,245,246,247]:
Aliphatic polyesters: include polylactic acid (PLA), polyglycolic acid (PGA), poly ε-caprolactone (PCL), poly (lactic-co-glycolide) (PLG) and poly-(3-hydroxybutyrate-co-3-hydroxybutyrate) (PHBV). They usually undergo degradation through hydrolysis of the ester group situated along their backbone with degradative by-products that are acidic in nature. The degradation rate of these polymers is easily controlled because they can be produced with a tailored structure. Their main drawback is their reduced bioactivity. PGA presents a rapid degradation (2–4 weeks), while PLA degradation takes months to years since it is more hydrophobic than PGA. To obtain intermediate degradation rates, PLGA with varying lactide/glycolide ratios are synthesised. PCL can be degraded by different agents—microorganisms, hydrolytic, enzymatic or intracellular agents. Compared with PLA and PGA, PCL has a slower degradation rate.
Aliphatic polycarbonates: they present low thermal stability and reduced mechanical properties. However, their controlled functional characteristics make them very interesting for bone tissue engineering applications. Among them, poly(trimethylene carbonate) (PTMC) has been used for fabricating bone tissue-engineered scaffolds with carbon-based nanomaterials using AM techniques.
Vinyl polymers: poly(vinyl alcohol) (PVA) is one of the most used vinyl polymers. It is a hydrophilic material. Hydrogels based on PVA show good biomechanical features, and they retain a large amount of water.
Polyurethanes (PUs): used for the fabrication of medical devices, especially long-term implants and biomedical products (e.g., cardiovascular catheters and diaphragms of blood pumps). The main disadvantage of PU is the toxicity of its degradative by-products, which can be reduced by using specific prepolymers.
Non-biodegradable polymers: despite their inability to degrade when implanted in the body, some different synthetic polymers have also been used in the manufacture of bone tissue-engineered scaffolds—polyether ether ketone (PEEK), polyvinylidene difluoride (PVDF) and acrylonitrile butadiene styrene (ABS).

4.3.2. Ceramic Matrices

Among ceramic materials, bioceramics exhibit properties, such as biocompatibility, mechanical compatibility, excellent surface compatibility, antithrombus effects, bactericidal effects and good physical and chemical stability, that make these materials suitable for being used for bone tissue-engineered scaffolds [248]. However, their primary ionic and/or covalent bonds make them relatively brittle. This inherent brittleness, together with low ductility, are major drawbacks for bioceramics and therefore limit their application [249].
Additive manufacturing has been investigated as a viable approach for the fabrication of ceramic-based bone tissue-engineered scaffolds by additive manufacturing, the most common ceramics used include:
Tricalcium phosphate (TCP): has good biocompatibility and does not present any cytotoxic reaction. Bone formation is favoured in contact with TCP due to the release of calcium and phosphate ions. Alpha-TCP (α-TCP) demonstrates a greater degree of solubility and a faster rate of degradation when compared to beta-TCP (β-TCP) [248]. The degradation rate of β-TCP is within the same range as the growth of mature new bone [250].
Hydroxyapatite (HA): its structure and composition are similar to the inorganic component of human bones. HA is highly biocompatible, non-toxic, osteoconductive and it gradually merges with the natural bone. Its main drawbacks are its low mechanical properties and relatively low degradation rate. To improve its mechanical strength, there are two paths: (i) use of reinforcements like other ceramics and (ii) fabrication of HA nanobioceramics [251].
Ca-Si-based ceramics: they present good compression properties and controllable degradation rate. They improve the rate of new bone formation and bone regeneration through a gradual release of Si and Ca ions. However, like many other bioceramics, their brittle nature and low toughness hinder their development in load-bearing applications [249].
Diopside, MgCaSi2O6 (Di): compared with HA and other bioceramics, offers improved mechanical strength. The Ca, Si and Mg containing ionic products from extracts of Di can stimulate osteoblast proliferation at low concentrations. However, its degradation rate is extremely slow [252].
Bioactive glasses (BGs): they can comprise of Na2O, CaO, SiO2 and P2O5. They are considered to be the most promising biomaterials in bone tissue engineering applications as they exhibit osteoinductive properties. Another attractive aspect of BGs is that their degradation rate can be regulated with respect to their chemical composition. Their poor mechanical properties (similar to many bioceramics) is the main drawback [249].

5. 3D Printed Scaffolds with Carbon-Based Nanomaterials

Other reviews have been reported the application of carbon-based nanomaterials for tissue-engineered bone scaffolds [71,253,254] fabricated by 3D printing [213,246,255,256,257]. Additional reviews have focused on the use of different materials for scaffold fabrication [258,259]. For this review, the focus is placed on biodegradable scaffolds with carbon-based nanomaterials fabricated using AM. To the best of the authors’ knowledge, a review with this focus has not been reported and there is currently a lack of knowledge regarding the effect of carbon-based nanomaterials during the printing process, how the carbon-based nanomaterials are introduced during the printing process and their effect on the final properties of the 3D printed scaffold. Therefore, the effect of carbon-based nanomaterials on scaffold properties has been studied, as well as the feasibility of using AM techniques in the fabrication of bone tissue-engineered scaffolds.

5.1. Biodegradable Polymer Scaffolds

• Material Extrusion
Due to its simplicity and speediness, FDM is the most used technology when the matrix is a polymer.
Many studies incorporating GO into different thermoplastic matrices have been found. Both biological and mechanical properties of the matrix were improved on the addition of GO. Melo et al. [260] and Unagolla et al. [261] reported improvement in the antimicrobial properties and the enhancement of cellular response. Melo et al. found an 80% increase in bacterial death after 24 h in contact with a PCL/GO scaffold.
Chen et al. [65] found that an increase of 167% in the compressive modulus was achieved when 5 wt.% GO was incorporated into a PLA–thermoplastic polyurethane (TPU) matrix and a maximum tensile modulus increase of 75.5% on the addition of 0.5 wt.% GO. This wt.% loading was also optimal in terms of cellular growth and proliferation of NIH3T3 mouse embryonic fibroblast cells. Belaid et al. [262] studied both mechanical and biological properties and reported an increase of 30% in Young’s modulus when 0.3 wt.% GO was added to PLA. When the proliferation of MC3T3-E1 cells was studied, they concluded that it was not until Day 7 that higher levels of viability were observed for scaffolds containing 0.2–0.3 wt.% GO loading when compared with pristine PLA.
All these studies introduced the nanomaterial using a solvent which was subsequently evaporated to obtain the filament to feed the printer. Figure 7 shows SEM images of PCL scaffolds with and without GO and it can be observed how GO addition did not affect the printing process as relatively similar geometries were achieved in all the cases.
G has also been used to improve the mechanical and biological properties of tissue-engineered bone scaffolds. Wang et al. [93] conducted in vitro and in vivo studies using G-PCL scaffolds for microcurrent therapy. They had previously found [143] an increase in cell attachment and proliferation due to the high surface area, elastic modulus and stiffness of the G-PCL scaffold. In this case, it was not until Day 14 when G at a loading level of approx. 0.8 wt.% demonstrated a statistically significant improvement in proliferation rate. Furthermore, G presented improved mechanical properties (i.e., compressive modulus and compressive strength) and cell affinity when compared to CNTs [263].
Sayar et al. [264] also used G powder as the reinforcement phase and FDM as the AM technique and following printing the scaffold was crosslinked using UV exposition. When a loading level of 3 wt.% G was incorporated into PTMC, an increase in tensile strength (100%) and electrical conductivity was demonstrated, which has potential for electrical stimulation. It was found that cell density, morphology and viability did not differ when compared to the pristine PTMC.
The mechanical properties of ABS scaffolds reinforced with GNPs at a loading level of 4 wt.% were investigated by Dul et al. [227]. They reported an increase in Young’s modulus; however, the adhesion between the matrix and reinforcement was relatively poor, which led to a decrease in tensile strength and strain at break.
Alam et al. [265] worked with a commercial filament of PLA loaded with carbon nanofibres and GNPs. They found that the presence of nanomaterials produced internal porosity, which resulted in a reduced compressive stiffness of 20%. In contrast, carbon nanomaterials improved hydrophilicity and apatite deposition.
Huang et al. [266] found that an addition of 3 wt.% of MWCNTs into PCL increased the compressive modulus, whilst the addition of 0.25–0.75 wt.% of MWCNTs did not affect this parameter. Nanoindentation properties improved from the addition of 0.75 and 3 wt.% CNTs. These improvements occurred due to an increase in polymer crystallinity due to CNT alignment. It was also found that smaller CNTs tended to agglomerate, thereby improving cell attachment and protein absorption. Mimicking natural bone tissue, Huang et al. [267], incorporated MWCNTs and nHA into PCL and found an increase in mechanical properties, cell proliferation, osteogenic differentiation and scaffold mineralisation.
For all studies, the scaffolds fabricated using FDM with carbon-based nanomaterials produced porous structures that were stable and the addition of a nanomaterial did not hinder the printing process.
Another technology derived from material extrusion is Direct Ink Writing. It was more extensively used for polymeric–ceramic matrices than polymeric. Jakus et al. [268] manufactured inks with high levels of G loading in a PLG-based matrix. The tensile modulus increased by 200% with a level of loading of 20 wt.% G. In vitro and in vivo studies demonstrated a good cellular response from approximately 30,000 cells at Day 1 in PLG to more than 50,000 when G was incorporated (Figure 8).
• Powder Bed Fusion
Researchers have also shown a high interest in SLS, especially using GO as the nanomaterial. For the application of this technology, different matrices have been investigated. PVA demonstrated very interesting properties for the application of bone tissue-engineered scaffolds. However, its low mechanical properties may be an obstacle in terms of its development. From this point, Shuai et al. [98] achieved an increase in compressive strength, Young’s modulus and tensile strength by 60, 152 and 69% upon adding GO into the matrix. This improvement was obtained for relatively low levels of loadings (2.5 wt.%), and increases beyond 2.5 wt.% resulted in the formation of agglomerates and ultimately the reduction in mechanical properties. Furthermore, they found an increase in cell adhesion and attachment of the GO to the PVA matrix.
Feng et al. [269] focused their work on reducing the degradation rate of PVA. They blended PVA with PEEK, a non-biodegradable polymer, which successfully reduced the degradation rate. Additionally, Feng et al. [269] reported that 1 wt.% GO addition improved the interfacial bonding between PEEK and PVA, which resulted in an improvement in mechanical properties (i.e., increases of 97 and 150% in compressive strength and compressive modulus). An increase in MG63 cell adhesion and proliferation was also reported when 1 wt.% GO was added to the PVA–PEEK matrix.
Shuai et al. [270] reported the improvement in the mechanical properties of GO-poly(L-lactic acid) (PLLA) scaffolds when fabricated using SLS and on adding Ag nanoparticles [271], which also enhanced antimicrobial activity due to the combination of the capturing effect of GO and killing effect of Ag.
Shuai et al. [99] also found that GO could be used to reinforce piezoelectric polymers for bone tissue engineering applications. Scaffolds containing 0.3 wt.% GO reported an improvement in compressive strength (100%) and tensile strength (25%) and cell adhesion was also enhanced by electrical charge excitation. However, although the polymer was not biodegradable, it could be applied in the field of bone scaffolds.
GO nanoparticles have not only been used during SLS technology, Feng et al. [272] achieved improvements for PHBV in terms of tensile strength and compressive strength (i.e., 94 and 52%) when 2 wt.% of ND particles and 1 wt.% of molybdenum disulfide (MoS2) nanosheets were added. MoS2 improved the dispersion of NDs due to its steric hindrance effect and vice versa and was found to be better dispersed within the matrix when it was added with NDs by the sandwiched octahedral ND particles.
All the studies regarding the polymer-based bone scaffolds with carbon-based nanomaterials when fabricated using SLS technology adopted a similar dispersion method of the nanoparticles—good GO dispersion was achieved using ultrasonication in water or a solvent that was evaporated to obtain powder for printing (Figure 9).
• Vat Photopolymerisation
Finally, vat photopolymerisation was the least used AM technique for the fabrication of polymer-based bone tissue-engineered scaffolds containing carbon-based nanomaterials.
Feng et al. [238] introduced 0.5 wt.% G into a commercial PU resin for SLA. G increased the tensile and flexural properties of the matrix. Feng et al. [240] also fabricated DLP samples comprising the same PU resin and 0.5 wt.% GNPs. In this case, the flexural modulus was improved by 14%, while fracture toughness increased by 28%. In both studies, Feng et al. used a solvent-free method to disperse the carbon-based nanomaterials in the matrix using ultrasonication. Consequently, gyroid scaffolds were fabricated by the two vat photopolymerisation technology (Figure 10). In Table 3 most relevant results of polymer biodegradable scaffolds found in literature are provided.

5.2. Biodegradable Ceramic Scaffolds

In relation to ceramic-based bone scaffolds, many researchers have focused their studies on biodegradable scaffolds reinforced with carbon-based nanomaterials fabricated using AM technology.
• Material Extrusion
In order to use technologies that are not optimally designed for ceramic feedstock, ceramics have been blended with polymers to get the required flowability. One interesting study reported in the literature was conducted by Lin et al. [68], who took advantage of FDM to obtain bone tissue-engineered scaffolds with 50 wt.% of PCL and 50 wt.% of calcium silicate-graphene (CaSi-G). Fluidity limited the amount of G that could be incorporated and at a 10 wt.% loading a relatively poor level of printability was observed. In vitro and in vivo studies found an increase in osteogenesis and cell proliferation by adding CaSi-G to the matrix (Figure 11). To adequately disperse the CaSi and G, a solvent was used and the CaSi-G was dispersed using ultrasonication followed by evaporation.
DIW has also been investigated as a suitable technique for the fabrication of ceramic-based bone tissue-engineered scaffolds. Two approaches have been investigated—the first is focused on the introduction of the nanomaterials into the ink by mechanical stirring [70,174,273,274] before printing the scaffold (Figure 12A) and the second method involves the addition of the nanomaterials into the printed ceramic structure in the form of a coating (Figure 12B) or by infiltration into the pores (Figure 12C) [54,69].
The preferred carbon-based nanomaterials for use with DIW is GO, and the most employed matrix is TCP with any polymer (either natural or synthetic). Wu et al. [54] investigated the potential of applying a coating prepared with a GO–water suspension (20 mg GO/40 mL water). They found that the incorporation of GO improved the proliferation, alkaline phosphatase activity and osteogenic gene expression of human bone marrow stromal cells (hBMSCs). Boga et al. [174] introduced 0.5 wt.% GO into a TCP/alginic acid (AA) matrix and studied the mechanical properties of the resultant scaffold in dry and wet (i.e., simulated body fluid) conditions. The addition of GO increased the Young’s modulus in dry conditions, but it did not affect the compressive strength in dry conditions or the mechanical properties in wet conditions. Furthermore, GO increased the biomineralisation capacity and the alkaline phosphatase activity.
Conversely, rGO exhibited relatively good responses, better even than GO in terms of compressive properties when tested under dry and wet conditions. Cabral et al. [70] incorporated rGO and GO into TCP-gelatin-chitosan scaffolds. rGO was shown to improve calcium deposition and alkaline phosphatase activity. When rGO infiltrated the pores of the scaffold [69], it showed an increase in cell proliferation and did not affect the ionic dissolution of the TCP.
Shah et al. [273] explored the application of two different inks: the first ink was loaded with HA (75 wt.%) and the second ink was loaded with G (60–70 wt.%) and both inks were used in conjunction with PLGA as the matrix. The final composition was 35:35:30, G:HA:PLGA by weight. They found that the composite demonstrated intermediate tensile properties, whilst under compression, the plastic behaviour was similar to that reported for the G-ink. The cellular response was lower than reported for each ink when used separately, but the mixed ink could be used for transition zones between two distinct tissue types.
Finally, DIW was used by Golçaves et al. [274] with a MWCNT-loaded ink (Figure 13). The level of loading for the ceramic (HA) matrix varied from 40–50 wt.% to a 60–40 wt.% of PCL. In terms of compressive properties, only the inclusion of low loading levels of MWCNTs increased the yield strength. Golçaves et al. [274] reported an optimum loading level of MWCNTs (0.75 wt.%) which increased both the mechanical and electrical properties and allowed the potential to apply an electrical stimulus for bone healing purposes. Furthermore, the incorporation of MWCNTs into PCL increased the levels of cell adhesion and spreading.
• Powder Bed Fusion
In contrast to the previously discussed AM techniques, SLS allows the application of ceramics without the requirement of adding a polymer since the raw material is already in the form of a powder. Hence, ceramic-based 3D scaffolds must be fabricated using powder bed fusion.
To date, the majority of studies using powder bed fusion technology for the fabrication of bone tissue-engineered scaffolds have involved G or CNT, and surprisingly no studies have reported the use of GO.
Gao et al. [73] and Shuai et al. [275] studied the incorporation of G into a ceramic composite (i.e., nano 58-S bioactive glass and CaSi) for the fabrication of 3D bone scaffolds using SLS. Both studies found that low levels of G loading significantly improved compressive and fracture properties. However, when the loading level was above 0.5 wt.%, these properties decreased due to the inability to adequately disperse the G within the matrix (Figure 14). Furthermore, Gao et al. [73] also studied cell biocompatibility and their scaffolds exhibited good responses in terms of in vitro cell cultures using osteoblast-like cells (i.e., MG-63).
GNPs were also investigated as nanomaterials by Shuai et al. [276] within a Di matrix. Results showed that due to the good dispersion of the 1 wt.% GNPs within the matrix, the mechanical properties were significantly increased (i.e., 102% in compressive strength and 34% in fracture toughness). MG-63 cells presented good attachment and spreading in vitro.
In the case of CNTs, different studies have reported a toughening effect when CNTs were added to a ceramic-based matrix. However, when the amount of nanomaterial was greater than an optimum level of loading (different in each case), the effect was reduced. Liu et al. [277] reported that 3 wt.% MWCNTs presented the most pronounced effect in terms of mechanical properties for BG-based scaffolds. In the case of Di, following the study by Shuai et al. [278], this level of loading was reduced to 2 wt.% MWCNTs. Finally, Liu-Lan et al. [279] found that the best mechanical properties were obtained when 0.2 wt.% CNTs were incorporated into the matrix. For levels of loading greater than 0.2 wt.%, agglomerates of CNTs formed, which resulted in a decrease in the mechanical properties. In all cases, the scaffolds showed good apatite-formation ability and cytocompatibility.
Finally, Liu et al. [280] studied a synergistic effect of 1 wt.% CNTs combined with 1 wt.% GNPs into a Di-based scaffold. The dispersion of both nanomaterials was better due to the combined presence of both nanomaterials; GNPs improved CNT dispersion due to their space hindrance effect and at the same time the GNP dispersion was improved by the tendency of the CNTs to self-align on the surface of GNPs, thereby constructing a 3D network that inhibited their stacking. The CNT-GDP-Di scaffold demonstrated a higher compressive strength and fracture toughness when compared to the same scaffold structure containing only one the of nanomaterials. Furthermore, evidence of good bioactivity and cytocompatibility were also reported.Table 4 provides the main results of ceramic biodegradable scaffolds obtained by additive manufacturing.

6. Potential Translability into Clinics

In spite of the promising results obtained from in vitro and in vivo tests, translability into clinics of scaffolds with CBNs requires special attention since it is mandatory to satisfy strict regulatory requirements of US-FDA and EU-MDR for their potential application.
Translation of bone tissue engineering scaffolds to the clinic finds several regulatory hurdles that must be considered from the design stage [281]. Despite these hurdles, there are already some FDA-approved Tissue Engineered products, such as TissueMend®, used to repair the rotator cuff, or Osteomesh® for craniofacial repair [282]. However, the introduction of CBNs as a nanofiller in bone tissue engineering introduces additional risks associated with possible toxicity, immunogenicity, cell culture adaptation/morphogenesis, or contamination which must be addressed to assure safety [283,284].
Depending on the material used to manufacture the scaffold, the regulatory process may change. In this respect, there are several FDA-approved synthetic polymers that have been incorporated as structural components in tissue engineering scaffolds. These include polyethylene glycol (PEG), polyglycolic acid (PGA), polylactic acid (PLLA), polycaprolactone (PCL) and their co-polymers [282]. Besides, some ceramic materials are FDA-approved, such as calcium phosphate cements [285].
In the case of the development of biodegradable scaffolds, it may require significant effort to establish the safety of the material as well as its degradation products, increasing time and cost for preclinical and clinical evaluations. The cost and effort required to translate fundamentally new technologies can be a significant barrier.
A substantial amount of theoretical modeling, in vitro characterisation and in vivo (i.e., in animals) studies are needed prior to beginning the regulatory approval process through the filing of an Investigational New Drug (IND) or Investigational Device Exemption (IDE) applications. One concern raised in the field of tissue-engineered scaffolds is the extent to which these studies are predictive of eventual function and performance in humans [286,287].
For the regulatory approval of a new therapeutic entity, the U.S. FDA presents four different pathways: tissues, biological products, drugs and medical devices. Bone tissue engineering finds unique challenges at this stage since, depending on its manifestation, many approaches may fall into more than one category, even all four of these categories. It implies an important difference in times; bringing a device to market takes an average of 3 to 7 years, compared with an average of 12 years for drugs [288,289].
Besides the regulatory approval, there are other business barriers that include obtaining external funding for product development, obtaining physician acceptance and, in some circumstances, obtaining approval for insurance reimbursement [290].

7. Conclusions and Future Perspectives

The present work is an overview on very recent developments in the field of biodegradable scaffolds; the aim is to analyze advantages, challenges and potential that the combination of two emerging and promising technologies can provide in this field—additive manufacturing and the use of CBN. Based on the studies, the fabrication of 3D printed biodegradable scaffolds modified with CBN have been shown to be an encouraging solution with interesting benefits—improved mechanical properties, enhanced biological activity, easy control of porosity and design, among others.
However, although considerable progress has been made, thereby providing a promising clinical platform for the repair and regeneration of bone, some aspects need to be examined in greater depth since the technology is still in its infancy. Some of the major research and technical challenges that the scientist community will need to address are:
-
Good performance of carbon-based nanomaterials is linked to a good dispersion within the matrix, one of the crucial and critical aspects to achieve during the manufacturing of carbon-based nanomaterial-derived bone tissue-engineered bone scaffolds.
-
It is important to study in-depth the influence that the level of nanomaterial loading exhibits on mechanical and biological properties since there is a balance to be attained to ensure the optimal properties are achieved for both. The optimal level of loading reported depends greatly on the study and ranges from 0.2 to 18 wt.%. In general, using a level of nanomaterial loading less than 1 wt.% offered the best results in terms of mechanical reinforcement.
-
AM technologies offer many advantages; however, materials need to have specific characteristics to allow the fabrication method to function both effectively and efficiently. The addition of nanomaterials can affect printability and therefore studying and optimising the addition and dispersion methods are crucial for the development of bone tissue-engineered scaffolds reinforced with carbon-based nanomaterials. Further studies regarding how nanomaterials affect the 3D printing technique and how to mitigate possible adverse effects need investigation.
-
The surface of the carbon-based nanomaterials is easily functionalized, and this functionalisation could improve the dispersion of the carbon-based nanomaterials and ultimately the mechanical performance. Conversely, carbon-based nanomaterials can be biofunctionalised to be used as biomolecular carriers, thereby increasing their bioactivity. Both approaches are interesting and relevant to the fabrication of bone tissue-engineered scaffolds using AM techniques. However, a better understanding of the regenerative effect and bioresponsiveness of chemically functionalised carbon-based nanomaterials and the mechanical performance of biofunctionalised carbon-based nanomaterials are required.
-
The last aspect that has to be highlighted relates to biodegradability. Ideally, bone tissue-engineered scaffolds should be biodegradable; this opens up a new research avenue—to study the behaviour of carbon-based nanomaterials and the associated degradative by-products when implanted into the body. Some studies have appeared related to this issue, but were inconclusive and inconsistent results were found. Further research on cytotoxicity and possible adverse environmental effects is necessary before these scaffolds can be clinically tested.
-
Safety and success in clinical translation need to be demonstrated by facing the regulatory and economic hundles. However, the future of this technology is bright, and the commitment of scientists and engineers will lead to a fruitful and impactful future in the coming decades.

Author Contributions

Conceptualization, E.P. and J.C.d.R.; methodology, S.L.d.A. and E.P.; formal analysis, N.D.; investigation, S.L.d.A.; writing—original draft preparation, S.L.d.A. and E.P.; writing—review and editing, J.C.d.R. and N.D.; supervision, E.P. and N.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Jones, M.S.; Waterson, B. Principles of management of long bone fractures and fracture healing. Surgery 2020, 38, 91–99. [Google Scholar] [CrossRef]
  2. Jimi, E.; Hirata, S.; Osawa, K.; Terashita, M.; Kitamura, C.; Fukushima, H. The current and future therapies of bone regeneration to repair bone defects. Int. J. Dent. 2012, 2012, 148261. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Dimitriou, R.; Tsiridis, E.; Giannoudis, P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36, 1392–1404. [Google Scholar] [CrossRef] [PubMed]
  4. Roddy, E.; DeBaun, M.R.; Daoud-Gray, A.; Yang, Y.P.; Gardner, M.J. Treatment of critical-sized bone defects: Clinical and tissue engineering perspectives. Eur. J. Orthop. Surg. Traumatol. 2018, 28, 351–362. [Google Scholar] [CrossRef]
  5. Nauth, A.; Schemitsch, E.; Norris, B.; Nollin, Z.; Watson, J.T. Critical-size bone defects: Is there a consensus for diagnosis and treatment? J. Orthop. Trauma 2018, 32, S7–S11. [Google Scholar] [CrossRef]
  6. Sohn, J.M.; In, Y.; Jeon, S.H.; Nho, J.Y.; Kim, M.S. Autologous impaction bone grafting for bone defects of the medial tibia plateau during primary total knee arthroplasty: Propensity score matched analysis with a minimum of 7-year follow-up. J. Arthroplasty 2018, 33, 2465–2470. [Google Scholar] [CrossRef]
  7. Shibuya, N.; Jupiter, D.C. Bone graft substitute: Allograft and xenograft. Clin. Podiatr. Med. Surg. 2015, 32, 21–34. [Google Scholar] [CrossRef]
  8. Kumar, V.; Ricks, M.; Aboul-Enin, S.; Dunlop, D.G. Long term results of impaction Bone grafting using a synthetic graft (Apapore) in revision hip surgery. J. Orthop. 2017, 14, 290–293. [Google Scholar] [CrossRef]
  9. Dimitriou, R.; Mataliotakis, G.I.; Angoules, A.G.; Kanakaris, N.K.; Giannoudis, P.V. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: A systematic review. Injury 2011, 42, S3–S15. [Google Scholar] [CrossRef]
  10. Damien, C.J.; Parsons, J.R. Bone graft and bone graft substitutes: A review of current technology and applications. J. Appl. Biomater. 1991, 2, 187–208. [Google Scholar] [CrossRef]
  11. Vail, T.P.; Urbaniak, J.R. Donor-site morbidity with use of vascularized autogenous fibular grafts. J. Bone Jt. Surg. 1996, 78, 204–211. [Google Scholar] [CrossRef] [PubMed]
  12. Arai, K.; Toh, S.; Tsubo, K.; Nishikawa, S.; Narita, S.; Miura, H. Complications of vascularized fibula graft for reconstruction of long bones. Plast. Reconstr. Surg. 2002, 109, 2301–2306. [Google Scholar] [CrossRef] [PubMed]
  13. Muramatsu, K.; Ihara, K.; Shigetomi, M.; Kawai, S. Femoral reconstruction by single, folded or double free vascularised fibular grafts. Br. J. Plast. Surg. 2004, 57, 550–555. [Google Scholar] [CrossRef] [PubMed]
  14. Spiegelberg, B.; Parratt, T.; Dheerendra, S.K.; Khan, W.S.; Jennings, R.; Marsh, D.R. Ilizarov principles of deformity correction. Ann. R. Coll. Surg. Engl. 2010, 92, 101–105. [Google Scholar] [CrossRef] [PubMed]
  15. Toon, D.H.; Khan, S.A.; Wong, K.H.Y. Lengthening of a below knee amputation stump with Ilizarov technique in a patient with a mangled leg. Chin. J. Traumatol.-Engl. Ed. 2019, 22, 364–367. [Google Scholar] [CrossRef] [PubMed]
  16. Cai, G.; Liu, W.; Xiong, J.; Liu, L.; Wang, D.; Yang, J. Functional reconstruction of hindfoot with total calcaneus and talus loss by ilizarov technique: A case report. J. Foot Ankle Surg. 2020, 59, 142–148. [Google Scholar] [CrossRef] [PubMed]
  17. Stuart, A.; Green, M.D. Skeletal defects. A comparison of bone grafting and bone transport for segmental skeletal defects. Clin. Orthop. Relat. Res. 1994, 301, 111–117. [Google Scholar]
  18. Blum, A.L.L.; Bongiovanni, J.C.; Morgan, S.J.; Flierl, M.A.; Dos Reis, F.B. Complications associated with distraction osteogenesis for infected nonunion of the femoral shaft in the presence of a bone defect: A retrospective series. J. Bone Joint Surg. Br. 2010, 92, 565–570. [Google Scholar] [CrossRef] [Green Version]
  19. Paley, D. Problems, obstacles, and complications of limb lengthening by Illizarov. Clin. Orthop. Relat. Res. 1990, 250, 81–104. [Google Scholar]
  20. Palatnik, Y.; Rozbruch, S.R. Femoral reconstruction using external fixation. Adv. Orthop. 2011, 2011, 967186. [Google Scholar] [CrossRef] [Green Version]
  21. Paley, D.; Catagni, M.; Argnani, F.; Prevot, J.; Bell, D.; Armstrong, P. Treatment of congenital pseudoarthrosis of the tibia using the ilizarov technique. Clin. Orthop. Relat. Res. 1992, 280, 81–93. [Google Scholar] [CrossRef]
  22. Zhai, J.; Weng, X.; Zhang, B.; Peng, H.; Bian, Y. Management of knee flexion contracture in haemophilia with the Ilizarov technique. Knee 2019, 26, 201–206. [Google Scholar] [CrossRef] [PubMed]
  23. Masquelet, A.C.; Begue, T. The concept of induced membrane for reconstruction of long bone defects. Orthop. Clin. N. Am. 2010, 41, 27–37. [Google Scholar] [CrossRef] [PubMed]
  24. Masquelet, A.C.; Fitoussi, F.; Begue, T.; Muller, G.P. Reconstruction of the long bones by the induced membrane and spongy autograft. Ann. Chir. Plast. Esthet. 2000, 45, 346–353. [Google Scholar]
  25. Shekaran, A.; García, J.R.; Clark, A.Y.; Kavanaugh, T.E.; Lin, A.S.; Guldberg, R.E.; García, A.J. Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle. Biomaterials 2014, 35, 5453–5461. [Google Scholar] [CrossRef] [Green Version]
  26. Seebach, C.; Henrich, D.; Kähling, C.; Wilhelm, K.; Tami, A.E.; Alini, M.; Marzi, I. Endothelial progenitor cells and mesenchymal stem cells seeded onto β-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng. Part A 2010, 16, 1961–1970. [Google Scholar] [CrossRef]
  27. Amini, A.R.; Laurencin, C.T.; Nukavarapu, S.P. Bone tissue engineering: Recent advances and challenges. Crit. Rev. Biomed. Eng. 2012, 40, 363–408. [Google Scholar] [CrossRef] [Green Version]
  28. Kellomäki, M.; Niiranen, H.; Puumanen, K.; Ashammakhi, N.; Waris, T.; Törmälä, P. Bioabsorbable scaffolds for guided bone regeneration and generation. Biomaterials 2000, 21, 2495–2505. [Google Scholar] [CrossRef]
  29. Meskinfam, M. 17—Polymer Scaffolds for Bone Regeneration. In Characterization of Polymeric Biomaterials; Elsevier Ltd.: Amsterdam, The Netherlands, 2017; pp. 441–475. ISBN 9780081007372. [Google Scholar]
  30. Chapekar, M.S. Tissue engineering: Challenges and opportunities. J. Biomed. Mater. Res. 2000, 53, 617–620. [Google Scholar] [CrossRef]
  31. Freed, L.E.; Vunjak-Novakoric, G.; Biron, R.J.; Eagles, D.B.; Lesnoy, D.C.; Barlow, S.K.; Langer, R. Biodegradable Polymer Scaffolds for Tissue Engineering. Biotechnology 1994, 12, 689–693. [Google Scholar] [CrossRef]
  32. Ribas, R.G.; Schatkoski, V.M.; do Amaral Montanheiro, T.L.; de Menezes, B.R.C.; Stegemann, C.; Leite, D.M.G.; Thim, G.P. Current advances in bone tissue engineering concerning ceramic and bioglass scaffolds: A review. Ceram. Int. 2019, 45, 21051–21061. [Google Scholar] [CrossRef]
  33. Alaribe, F.N.; Manoto, S.L.; Motaung, S.C.K.M. Scaffolds from biomaterials: Advantages and limitations in bone and tissue engineering. Biologia 2016, 71, 353–366. [Google Scholar] [CrossRef]
  34. Pina, S.; Oliveira, J.M.; Reis, R.L. Natural-based nanocomposites for bone tissue engineering and regenerative medicine: A review. Adv. Mater. 2015, 27, 1143–1169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Bonfield, W.; Grynpas, M.D.; Tully, A.E.; Bowman, J.; Abram, J. Hydroxyapatite reinforced polyethylene - a mechanically compatible implant material for bone replacement. Biomaterials 1981, 2, 185–186. [Google Scholar] [CrossRef]
  36. Bharadwaz, A.; Jayasuriya, A.C. Recent trends in the application of widely used natural and synthetic polymer nanocomposites in bone tissue regeneration. Mater. Sci. Eng. C 2020, 110, 110698. [Google Scholar] [CrossRef]
  37. Gandolfi, M.G.; Zamparini, F.; Degli Esposti, M.; Chiellini, F.; Fava, F.; Fabbri, P.; Taddei, P.; Prati, C. Highly porous polycaprolactone scaffolds doped with calcium silicate and dicalcium phosphate dihydrate designed for bone regeneration. Mater. Sci. Eng. C 2019, 102, 341–361. [Google Scholar] [CrossRef]
  38. Drupitha, M.P.; Das, B.; Parameswaran, R.; Dhara, S.; Nando, G.B.; Naskar, K. Hybrid electrospun fibers based on TPU-PDMS and spherical nanohydroxyapatite for bone tissue engineering. Mater. Today Commun. 2018, 16, 264–273. [Google Scholar] [CrossRef]
  39. Moeini, S.; Mohammadi, M.R.; Simchi, A. In-situ solvothermal processing of polycaprolactone/hydroxyapatite nanocomposites with enhanced mechanical and biological performance for bone tissue engineering. Bioact. Mater. 2017, 2, 146–155. [Google Scholar] [CrossRef]
  40. Morelli, S.; Salerno, S.; Holopainen, J.; Ritala, M.; De Bartolo, L. Osteogenic and osteoclastogenic differentiation of co-cultured cells in polylactic acid-nanohydroxyapatite fiber scaffolds. J. Biotechnol. 2015, 204, 53–62. [Google Scholar] [CrossRef]
  41. Kim, M.H.; Yun, C.; Chalisserry, E.P.; Lee, Y.W.; Kang, H.W.; Park, S.H.; Jung, W.K.; Oh, J.; Nam, S.Y. Quantitative analysis of the role of nanohydroxyapatite (nHA) on 3D-printed PCL/nHA composite scaffolds. Mater. Lett. 2018, 220, 112–115. [Google Scholar] [CrossRef]
  42. Ba Linh, N.T.; Lee, K.H.; Lee, B.T. Functional nanofiber mat of polyvinyl alcohol/gelatin containing nanoparticles of biphasic calcium phosphate for bone regeneration in rat calvaria defects. J. Biomed. Mater. Res. Part A 2013, 101A, 2412–2423. [Google Scholar] [CrossRef] [PubMed]
  43. Ezati, M.; Safavipour, H.; Houshmand, B.; Faghihi, S. Development of a PCL/gelatin/chitosan/β-TCP electrospun composite for guided bone regeneration. Prog. Biomater. 2018, 7, 225–237. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Chern, M.J.; Yang, L.Y.; Shen, Y.K.; Hung, J.H. 3D scaffold with PCL combined biomedical ceramic materials for bone tissue regeneration. Int. J. Precis. Eng. Manuf. 2013, 14, 2201–2207. [Google Scholar] [CrossRef]
  45. Arumugam, R.; Subramanyam, V.; Chinnadurai, R.K.; Srinadhu, E.S.; Subramanian, B.; Nallani, S. Development of novel mechanically stable porous nanocomposite (PVDF-PMMA/HAp/TiO2) film scaffold with nanowhiskers surface morphology for bone repair applications. Mater. Lett. 2019, 236, 694–696. [Google Scholar] [CrossRef]
  46. Guo, W.; Xu, L.; Feng, P.; Gu, Y.; Shuai, C. In-situ growth of silica nano-protrusions on halloysite nanotubes for interfacial reinforcement in polymer/halloysite scaffolds. Appl. Surf. Sci. 2020, 513, 145772. [Google Scholar] [CrossRef]
  47. Hasan, A.; Waibhaw, G.; Saxena, V.; Pandey, L.M. Nano-biocomposite scaffolds of chitosan, carboxymethyl cellulose and silver nanoparticle modified cellulose nanowhiskers for bone tissue engineering applications. Int. J. Biol. Macromol. 2018, 111, 923–934. [Google Scholar] [CrossRef]
  48. Marsich, E.; Bellomo, F.; Turco, G.; Travan, A.; Donati, I.; Paoletti, S. Nano-composite scaffolds for bone tissue engineering containing silver nanoparticles: Preparation, characterization and biological properties. J. Mater. Sci. Mater. Med. 2013, 24, 1799–1807. [Google Scholar] [CrossRef]
  49. Alam, F.; Shukla, V.R.; Varadarajan, K.M.; Kumar, S. Microarchitected 3D printed polylactic acid (PLA) nanocomposite scaffolds for biomedical applications. J. Mech. Behav. Biomed. Mater. 2020, 103, 103576. [Google Scholar] [CrossRef]
  50. Prakash, J.; Prema, D.; Venkataprasanna, K.S.; Balagangadharan, K. International Journal of Biological Macromolecules Nanocomposite chitosan film containing graphene oxide/hydroxyapatite/gold for bone tissue engineering. Int. J. Biol. Macromol. 2020, 154, 62–71. [Google Scholar] [CrossRef]
  51. Abdelrasoul, G.N.; Farkas, B.; Romano, I.; Diaspro, A.; Beke, S. Nanocomposite scaffold fabrication by incorporating gold nanoparticles into biodegradable polymer matrix: Synthesis, characterization, and photothermal effect. Mater. Sci. Eng. C 2015, 56, 305–310. [Google Scholar] [CrossRef]
  52. Erol, M.; Özyuĝuran, A.; Özarpat, Ö.; Küçükbayrak, S. 3D Composite scaffolds using strontium containing bioactive glasses. J. Eur. Ceram. Soc. 2012, 32, 2747–2755. [Google Scholar] [CrossRef]
  53. Gönen, S.Ö.; Taygun, M.E.; Küçükbayrak, S. Fabrication of bioactive glass containing nanocomposite fiber mats for bone tissue engineering applications. Compos. Struct. 2016, 138, 96–106. [Google Scholar] [CrossRef]
  54. Golzar, H.; Mohammadrezaei, D.; Yadegari, A.; Rasoulianboroujeni, M.; Hashemi, M.; Omidi, M.; Yazdian, F.; Shalbaf, M.; Tayebi, L. Incorporation of functionalized reduced graphene oxide/magnesium nanohybrid to enhance the osteoinductivity capability of 3D printed calcium phosphate-based scaffolds. Compos. Part B Eng. 2020, 185, 107749. [Google Scholar] [CrossRef]
  55. Shen, J.; Wang, W.; Zhai, X.; Chen, B.; Qiao, W.; Li, W.; Li, P.; Zhao, Y.; Meng, Y.; Qian, S.; et al. 3D-printed nanocomposite scaffolds with tunable magnesium ionic microenvironment induce in situ bone tissue regeneration. Appl. Mater. Today 2019, 16, 493–507. [Google Scholar] [CrossRef]
  56. Chao, T.I.; Xiang, S.; Chen, C.S.; Chin, W.C.; Nelson, A.J.; Wang, C.; Lu, J. Carbon nanotubes promote neuron differentiation from human embryonic stem cells. Biochem. Biophys. Res. Commun. 2009, 384, 426–430. [Google Scholar] [CrossRef] [PubMed]
  57. Chao, T.I.; Xiang, S.; Lipstate, J.F.; Wang, C.; Lu, J. Poly(methacrylic acid)-grafted carbon nanotube scaffolds enhance differentiation of hESCs into neuronal cells. Adv. Mater. 2010, 22, 3542–3547. [Google Scholar] [CrossRef]
  58. Xie, X.; Wang, W.; Cheng, J.; Liang, H.; Lin, Z.; Zhang, T.; Lu, Y.; Li, Q. Bilayer pifithrin-α loaded extracellular matrix/PLGA scaffolds for enhanced vascularized bone formation. Colloids Surfaces B Biointerfaces 2020, 190, 110903. [Google Scholar] [CrossRef]
  59. Rasoulianboroujeni, M.; Fahimipour, F.; Shah, P.; Khoshroo, K.; Tahriri, M.; Eslami, H.; Yadegari, A.; Dashtimoghadam, E.; Tayebi, L. Development of 3D-printed PLGA/TiO2 nanocomposite scaffolds for bone tissue engineering applications. Mater. Sci. Eng. C 2019, 96, 105–113. [Google Scholar] [CrossRef]
  60. Honda, M.; Morikawa, N.; Hata, K.; Yada, T.; Morita, S.; Ueda, M.; Kimata, K. Rat costochondral cell characteristics on poly (L-lactide-co-ε-caprolactone) scaffolds. Biomaterials 2003, 24, 3511–3519. [Google Scholar] [CrossRef]
  61. Walejewska, E.; Idaszek, J.; Heljak, M.; Chlanda, A.; Choinska, E.; Hasirci, V.; Swieszkowski, W. The effect of introduction of filament shift on degradation behaviour of PLGA- and PLCL-based scaffolds fabricated via additive manufacturing. Polym. Degrad. Stab. 2020, 171, 109030. [Google Scholar] [CrossRef]
  62. Mishra, R.; Varshney, R.; Das, N.; Sircar, D.; Roy, P. Synthesis and characterization of gelatin-PVP polymer composite scaffold for potential application in bone tissue engineering. Eur. Polym. J. 2019, 119, 155–168. [Google Scholar] [CrossRef]
  63. Chen, W.; Ma, J.; Zhu, L.; Morsi, Y.; EI-Hamshary, H.; Al-Deyab, S.S.; Mo, X. Superelastic, superabsorbent and 3D nanofiber-assembled scaffold for tissue engineering. Colloids Surfaces B Biointerfaces 2016, 142, 165–172. [Google Scholar] [CrossRef] [PubMed]
  64. Xu, T.; Liang, Z.; Ding, B.; Feng, Q.; Fong, H. Polymer blend nanofibers containing polycaprolactone as biocompatible and biodegradable binding agent to fabricate electrospun three-dimensional scaffolds/structures. Polymer 2018, 151, 299–306. [Google Scholar] [CrossRef]
  65. Chen, Q.; Mangadlao, J.D.; Wallat, J.; De Leon, A.; Pokorski, J.K.; Advincula, R.C. 3D printing biocompatible polyurethane/poly(lactic acid)/graphene oxide nanocomposites: Anisotropic properties. ACS Appl. Mater. Interfaces 2017, 9, 4015–4023. [Google Scholar] [CrossRef] [PubMed]
  66. Hassanajili, S.; Karami-Pour, A.; Oryan, A.; Talaei-Khozani, T. Preparation and characterization of PLA/PCL/HA composite scaffolds using indirect 3D printing for bone tissue engineering. Mater. Sci. Eng. C 2019, 104, 109960. [Google Scholar] [CrossRef] [PubMed]
  67. Shahrezaee, M.; Salehi, M.; Keshtkari, S.; Oryan, A.; Kamali, A.; Shekarchi, B. In vitro and in vivo investigation of PLA/PCL scaffold coated with metformin-loaded gelatin nanocarriers in regeneration of critical-sized bone defects. Nanomed. Nanotechnol. Biol. Med. 2018, 14, 2061–2073. [Google Scholar] [CrossRef]
  68. Lin, Y.H.; Chuang, T.Y.; Chiang, W.H.; Chen, I.W.P.; Wang, K.; Shie, M.Y.; Chen, Y.W. The synergistic effects of graphene-contained 3D-printed calcium silicate/poly-ε-caprolactone scaffolds promote FGFR-induced osteogenic/angiogenic differentiation of mesenchymal stem cells. Mater. Sci. Eng. C 2019, 104, 109887. [Google Scholar] [CrossRef]
  69. Wu, C.; Xia, L.; Han, P.; Xu, M.; Fang, B.; Wang, J.; Chang, J.; Xiao, Y. Graphene-oxide-modified β-tricalcium phosphate bioceramics stimulate in vitro and in vivo osteogenesis. Carbon N. Y. 2015, 93, 116–129. [Google Scholar] [CrossRef]
  70. Cabral, C.S.D.; Miguel, S.P.; de Melo-Diogo, D.; Louro, R.O.; Correia, I.J. Green reduced graphene oxide functionalized 3D printed scaffolds for bone tissue regeneration. Carbon N. Y. 2019, 146, 513–523. [Google Scholar] [CrossRef]
  71. Eivazzadeh-Keihan, R.; Maleki, A.; de la Guardia, M.; Bani, M.S.; Chenab, K.K.; Pashazadeh-Panahi, P.; Baradaran, B.; Mokhtarzadeh, A.; Hamblin, M.R. Carbon based nanomaterials for tissue engineering of bone: Building new bone on small black scaffolds: A review. J. Adv. Res. 2019, 18, 185–201. [Google Scholar] [CrossRef]
  72. Madannejad, R.; Shoaie, N.; Jahanpeyma, F.; Darvishi, M.H.; Azimzadeh, M.; Javadi, H. Toxicity of carbon-based nanomaterials: Reviewing recent reports in medical and biological systems. Chem. Biol. Interact. 2019, 307, 206–222. [Google Scholar] [CrossRef] [PubMed]
  73. Gao, C.; Liu, T.; Shuai, C.; Peng, S. Enhancement mechanisms of graphene in nano-58S bioactive glass scaffold: Mechanical and biological performance. Sci. Rep. 2014, 4, 4712. [Google Scholar] [CrossRef] [PubMed]
  74. Iijima, S. Helical microtubule of graphitic carbon. Nature 1991, 354, 56–58. [Google Scholar] [CrossRef]
  75. Iijima, S.; Ichihashi, T. Single-shell carbon nanotubes of 1-nm diameter. Nature 1993, 363, 603–605. [Google Scholar] [CrossRef]
  76. Saifuddin, N.; Raziah, A.Z.; Junizah, A.R. Carbon nanotubes: A review on structure and their interaction with proteins. J. Chem. 2013, 2013, 676815. [Google Scholar] [CrossRef]
  77. Eatemadi, A.; Daraee, H.; Karimkhanloo, H.; Kouhi, M.; Zarghami, N.; Akbarzadeh, A.; Abasi, M.; Hanifehpour, Y.; Joo, S.W. Carbon nanotubes: Properties, synthesis, purification, and medical applications. Nanoscale Res. Lett. 2014, 9, 393. [Google Scholar] [CrossRef] [Green Version]
  78. Dunne, N.; Mitchell, C. Biomedical/Bioengineering Applications of Carbon Nanotube-Based Nanocomposites; Woodhead Publishing Limited: Sawston, UK, 2011; ISBN 9781845697617. [Google Scholar]
  79. Shao, S.; Zhou, S.; Li, L.; Li, J.; Luo, C.; Wang, J.; Li, X. Osteoblast function on electrically conductive electrospun PLA/MWCNTs nano fi bers. Biomaterials 2011, 32, 2821–2833. [Google Scholar] [CrossRef]
  80. Brown, M.J.; Loew, L.M. Electric field-directed fibroblast locomotion involves cell surface molecular reorganization and is calcium independent. J. Cell Biol. 1994, 127, 117–128. [Google Scholar] [CrossRef] [Green Version]
  81. Li, X.; Kolega, J. Effects of direct current electric fields on cell migration and actin filament distribution in bovine vascular endothelial cells. J. Vasc. Res. 2002, 39, 391–404. [Google Scholar] [CrossRef]
  82. Magiera, A.; Markowski, J.; Menaszek, E.; Pilch, J.; Blazewicz, S. PLA-based hybrid and composite electrospun fibrous scaffolds as potential materials for tissue engineering. J. Nanomater. 2017, 2017, 924802. [Google Scholar] [CrossRef]
  83. Lahiri, D.; Rouzaud, F.; Namin, S.; Keshri, A.K.; Valdés, J.J.; Kos, L.; Tsoukias, N.; Agarwal, A. Carbon nanotube reinforced polylactide-caprolactone copolymer: Mechanical strengthening and interaction with human osteoblasts in vitro. ACS Appl. Mater. Interfaces 2009, 1, 2470–2476. [Google Scholar] [CrossRef] [PubMed]
  84. Abarrategi, A.; Gutiérrez, M.C.; Moreno-Vicente, C.; Hortigüela, M.J.; Ramos, V.; López-Lacomba, J.L.; Ferrer, M.L.; del Monte, F. Multiwall carbon nanotube scaffolds for tissue engineering purposes. Biomaterials 2008, 29, 94–102. [Google Scholar] [CrossRef] [PubMed]
  85. Wang, S.-F.; Shen, L.; Zhang, W.-D.; Tong, Y.-J. Preparation and Mechanical Properties of Chitosan/Carbon Nanotubes Composites. Biomacromolecules 2005, 6, 3067–3072. [Google Scholar] [CrossRef] [PubMed]
  86. Shi, X.; Sitharaman, B.; Pham, Q.P.; Liang, F.; Wu, K.; Edward Billups, W.; Wilson, L.J.; Mikos, A.G. Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials 2007, 28, 4078–4090. [Google Scholar] [CrossRef] [Green Version]
  87. Sitharaman, B.; Shi, X.; Walboomers, X.F.; Liao, H.; Cuijpers, V.; Wilson, L.J.; Mikos, A.G.; Jansen, J.A. In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone 2008, 43, 362–370. [Google Scholar] [CrossRef]
  88. Geim, A.K.; Novoselov, K.S. The rise of graphene. Nat. Mater. 2007, 6, 183–191. [Google Scholar] [CrossRef]
  89. Tiwari, S.K.; Kumar, V.; Huczko, A.; Oraon, R.; De Adhikari, A.; Nayak, G.C. Magical Allotropes of Carbon: Prospects and Applications. Crit. Rev. Solid State Mater. Sci. 2016, 41, 257–317. [Google Scholar] [CrossRef]
  90. Tiwari, S.K.; Sahoo, S.; Wang, N.; Huczko, A. Graphene research and their outputs: Status and prospect. J. Sci. Adv. Mater. Devices 2020. [Google Scholar] [CrossRef]
  91. Ma, T.; Liu, Z.; Wen, J.; Gao, Y.; Ren, X.; Chen, H.; Jin, C.; Ma, X.L.; Xu, N.; Cheng, H.M.; et al. Tailoring the thermal and electrical transport properties of graphene films by grain size engineering. Nat. Commun. 2017, 8, 14486. [Google Scholar] [CrossRef]
  92. Prusty, K.; Barik, S.; Swain, S.K. A Corelation Between the Graphene Surface Area, Functional Groups, Defects, and Porosity on the Performance of the Nanocomposites; Elsevier Inc.: Amsterdam, The Netherlands, 2019; ISBN 9780128145531. [Google Scholar]
  93. Wang, W.; Junior, J.R.P.; Nalesso, P.R.L.; Musson, D.; Cornish, J.; Mendonça, F.; Caetano, G.F.; Bártolo, P. Engineered 3D printed poly(ε-caprolactone)/graphene scaffolds for bone tissue engineering. Mater. Sci. Eng. C 2019, 100, 759–770. [Google Scholar] [CrossRef]
  94. Fan, H.; Wang, L.; Zhao, K.; Li, N.; Shi, Z.; Ge, Z.; Jin, Z. Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites. Biomacromolecules 2010, 11, 2345–2351. [Google Scholar] [CrossRef]
  95. Mohan, V.B.; Lau, K.T.; Hui, D.; Bhattacharyya, D. Graphene-based materials and their composites: A review on production, applications and product limitations. Compos. Part B Eng. 2018, 142, 200–220. [Google Scholar] [CrossRef]
  96. Raslan, A.; Saenz, L.; Ciriza, J.; Pedraz, J.L. Graphene oxide and reduced graphene oxide-based scaffolds in regenerative medicine. Int. J. Pharm. 2020, 580, 119226. [Google Scholar] [CrossRef]
  97. Liu, L.; Zhang, J.; Zhao, J.; Liu, F. Mechanical properties of graphene oxides. Nanoscale 2012, 4, 5910. [Google Scholar] [CrossRef] [PubMed]
  98. Shuai, C.; Feng, P.; Gao, C.; Shuai, X.; Xiao, T.; Peng, S. Graphene oxide reinforced poly(vinyl alcohol): Nanocomposite scaffolds for tissue engineering applications. RSC Adv. 2015, 5, 25416–25423. [Google Scholar] [CrossRef]
  99. Shuai, C.; Zeng, Z.; Yang, Y.; Qi, F.; Peng, S.; Yang, W.; He, C.; Wang, G.; Qian, G. Graphene oxide assists polyvinylidene fluoride scaffold to reconstruct electrical microenvironment of bone tissue. Mater. Des. 2020, 190, 108564. [Google Scholar] [CrossRef]
  100. Nie, W.; Peng, C.; Zhou, X.; Chen, L.; Wang, W.; Zhang, Y.; Ma, P.X.; He, C. Three-dimensional porous scaffold by self-assembly of reduced graphene oxide and nano-hydroxyapatite composites for bone tissue engineering. Carbon N. Y. 2017, 116, 325–337. [Google Scholar] [CrossRef]
  101. Correa, E.; Moncada, M.E.; Gutiérrez, O.D.; Vargas, C.A.; Zapata, V.H. Characterization of polycaprolactone/rGO nanocomposite scaffolds obtained by electrospinning. Mater. Sci. Eng. C 2019, 103, 109773. [Google Scholar] [CrossRef]
  102. Zhang, Q.; Liu, X.; Meng, H.; Liu, S.; Zhang, C. Reduction pathway-dependent cytotoxicity of reduced graphene oxide. Environ. Sci. Nano 2018, 5, 1361–1371. [Google Scholar] [CrossRef]
  103. Wang, Y.; Chen, Y.; Lacey, S.D.; Xu, L.; Xie, H.; Li, T.; Danner, V.A.; Hu, L. Reduced graphene oxide film with record-high conductivity and mobility. Mater. Today 2018, 21, 186–192. [Google Scholar] [CrossRef]
  104. Kaur, T.; Thirugnanam, A.; Pramanik, K. Effect of carboxylated graphene nanoplatelets on mechanical and in-vitro biological properties of polyvinyl alcohol nanocomposite scaffolds for bone tissue engineering. Mater. Today Commun. 2017, 12, 34–42. [Google Scholar] [CrossRef]
  105. Cheng, Y.W.; Wang, S.H.; Liu, C.M.; Chien, M.Y.; Hsu, C.C.; Liu, T.Y. Amino-modified graphene oxide nanoplatelets for photo-thermal and anti-bacterial capability. Surf. Coatings Technol. 2020, 385, 125441. [Google Scholar] [CrossRef]
  106. Kroto, H.W.; Health, J.R.; O’Brien, S.C.; Curl, R.F.; Smalley, R.E. C60: Buckminsterfullerene. Nature 1985, 318, 162–163. [Google Scholar] [CrossRef]
  107. Goodarzi, S.; Da Ros, T.; Conde, J.; Sefat, F.; Mozafari, M. Fullerene: Biomedical engineers get to revisit an old friend. Mater. Today 2017, 20, 460–480. [Google Scholar] [CrossRef] [Green Version]
  108. Sitharaman, B.; Shi, X.; Tran, L.A.; Spicer, P.P.; Rusakova, I.; Wilson, L.J.; Mikos, A.G. Injectable in situ cross-linkable nanocomposites of biodegradable polymers and carbon nanostructures for bone tissue engineering. J. Biomater. Sci. Polym. Ed. 2007, 18, 655–671. [Google Scholar] [CrossRef] [Green Version]
  109. Kumar, R.; Kumar, V.B.; Gedanken, A. Sonochemical synthesis of carbon dots, mechanism, effect of parameters, and catalytic, energy, biomedical and tissue engineering applications. Ultrason.-Sonochemistry 2020, 64, 105009. [Google Scholar] [CrossRef]
  110. Ghosal, K.; Ghosh, A. Carbon dots: The next generation platform for biomedical applications. Mater. Sci. Eng. C 2019, 96, 887–903. [Google Scholar] [CrossRef]
  111. Shang, W.; Zhang, X.; Zhang, M.; Fan, Z.; Sun, Y.; Han, M.; Fan, L. The uptake mechanism and biocompatibility of graphene quantum dots with human neural stem cells. Nanoscale 2014, 6, 5799–5806. [Google Scholar] [CrossRef]
  112. Gogoi, S.; Maji, S.; Mishra, D.; Devi, K.S.P.; Maiti, T.K.; Karak, N. Nano-Bio Engineered Carbon Dot-Peptide Functionalized Water Dispersible Hyperbranched Polyurethane for Bone Tissue Regeneration. Macromol. Biosci. 2016, 17, 1–15. [Google Scholar] [CrossRef]
  113. Wang, X.; Sun, X.; Lao, J.; He, H.; Cheng, T.; Wang, M.; Wang, S.; Huang, F. Multifunctional graphene quantum dots for simultaneous targeted cellular imaging and drug delivery. Colloids Surfaces B Biointerfaces 2014, 122, 638–644. [Google Scholar] [CrossRef]
  114. Pereira, F.A.S.; Salles, G.N.; Rodrigues, B.V.M.; Marciano, F.R.; Pacheco-Soares, C.; Lobo, A.O. Diamond nanoparticles into poly (lactic acid) electrospun fibers: Cytocompatible and bioactive scaffolds with enhanced wettability and cell adhesion. Mater. Lett. 2016, 183, 420–424. [Google Scholar] [CrossRef]
  115. Grausova, L.; Kromka, A.; Burdikova, Z.; Eckhardt, A.; Rezek, B.; Vacik, J.; Haenen, K.; Lisa, V.; Bacakova, L. Enhanced growth and osteogenic differentiation of human osteoblast-like cells on boron-doped nanocrystalline diamond thin films. PLoS ONE 2011, 6, e20943. [Google Scholar] [CrossRef] [Green Version]
  116. Parizek, M.; Douglas, T.E.; Novotna, K.; Kromka, A.; Brady, M.A.; Renzing, A.; Voss, E.; Jarosova, M.; Palatinus, L.; Tesarek, P.; et al. Nanofibrous poly(lactide-co-glycolide) membranes loaded with diamond nanoparticles as promising substrates for bone tissue engineering. Int. J. Nanomed. 2012, 7, 1931–1951. [Google Scholar] [CrossRef] [Green Version]
  117. Han, X.; Li, S.; Peng, Z.; Al-Yuobi, A.O.; Bashammakh, A.S.O.; El-Shahawi, M.S.; Leblanc, R.M. Interactions between carbon nanomaterials and biomolecules. J. Oleo Sci. 2016, 65, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  118. Dizaj, S.M.; Mennati, A.; Jafari, S.; Khezri, K.; Adibkia, K. Antimicrobial activity of carbon-based nanoparticles. Adv. Pharm. Bull. 2015, 5, 19–23. [Google Scholar] [CrossRef]
  119. Kang, S.; Herzberg, M.; Rodrigues, D.F.; Elimelech, M. Antibacterial effects of carbon nanotubes: Size does matter! Langmuir 2008, 24, 6409–6413. [Google Scholar] [CrossRef] [PubMed]
  120. Sivashankari, P.R.; Prabaharan, M. Bioactive Nanomaterials/Chitosan Composites as Scaffolds for Tissue Regeneration; Elsevier Ltd.: Amsterdam, The Netherlands, 2019; ISBN 9780081025536. [Google Scholar]
  121. Chalidis, B.; Sachinis, N.; Assiotis, A.; Maccauro, G. Stimulation of bone formation and fracture healing with pulsed electromagnetic fields: Biologic responses and clinical implications. Int. J. Immunopathol. Pharmacol. 2011, 24, 17–20. [Google Scholar] [CrossRef]
  122. Masureik, C.; Eriksson, C. Preliminary clinical evaluation of the effect of small electrical currents on the healing of jaw fractures. Clin. Orthop. Relat. Res. 1977, 124, 84–91. [Google Scholar] [CrossRef]
  123. Levin, M. Molecular bioelectricity: How endogenous voltage potentials control cell behavior and instruct pattern regulation in vivo. Mol. Biol. Cell 2014, 25, 3835–3850. [Google Scholar] [CrossRef]
  124. Borsalino, G.; Bagnacani, M.; Bettati, E.; Fornaciari, F.; Rocchi, R.; Uluhogian, S.; Ceccherelli, G.; Cadossi, R.; Traina, G.C. Electrical stimulation of human femoral intertrochanteric osteotomies: Double-blind study. Clin. Orthop. Relat. Res. 1988, 256–263. [Google Scholar] [CrossRef]
  125. Turk, M.; Deliormanll, A.M. Electrically conductive borate-based bioactive glass scaffolds for bone tissue engineering applications. J. Biomater. Appl. 2017, 32, 28–39. [Google Scholar] [CrossRef] [PubMed]
  126. Cai, Q.; Subramani, K.; Mathew, R.T.; Yang, X. Chapter 18—Carbon nanomaterials for implant dentistry and bone tissue engineering. In Nanobiomaterials in Clinical Dentistry; Elsevier Inc.: Amsterdam, The Netherlands, 2019; pp. 429–468. ISBN 9780128158869. [Google Scholar]
  127. Ogunsona, E.O.; Muthuraj, R.; Ojogbo, E.; Valerio, O.; Mekonnen, T.H. Engineered nanomaterials for antimicrobial applications: A review. Appl. Mater. Today 2020, 18, 100473. [Google Scholar] [CrossRef]
  128. Ruparelia, J.P.; Chatterjee, A.K.; Duttagupta, S.P.; Mukherji, S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008, 4, 707–716. [Google Scholar] [CrossRef]
  129. Akhavan, O.; Ghaderi, E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano 2010, 4, 5731–5736. [Google Scholar] [CrossRef] [PubMed]
  130. Parandhaman, T.; Das, A.; Ramalingam, B.; Samanta, D.; Sastry, T.P.; Mandal, A.B.; Das, S.K. Antimicrobial behavior of biosynthesized silica-silver nanocomposite for water disinfection: A mechanistic perspective. J. Hazard. Mater. 2015, 290, 117–126. [Google Scholar] [CrossRef]
  131. Gunawan, C.; Teoh, W.Y.; Marquis, C.P.; Amal, R. Cytotoxic origin of copper(II) oxide nanoparticles: Comparative studies with micron-sized particles, leachate, and metal salts. ACS Nano 2011, 5, 7214–7225. [Google Scholar] [CrossRef]
  132. Arias, L.R.; Yang, L. Inactivation of bacterial pathogens by carbon nanotubes in suspensions. Langmuir 2009, 25, 3003–3012. [Google Scholar] [CrossRef]
  133. Yang, C.; Mamouni, J.; Tang, Y.; Yang, L. Antimicrobial activity of single-walled carbon nanotubes: Length effect. Langmuir 2010, 26, 16013–16019. [Google Scholar] [CrossRef]
  134. Azimi, S.; Behin, J.; Abiri, R.; Rajabi, L.; Derakhshan, A.A.; Karimnezhad, H. Synthesis, characterization and antibacterial activity of chlorophyllin functionalized graphene oxide nanostructures. Sci. Adv. Mater. 2014, 6, 771–781. [Google Scholar] [CrossRef]
  135. Yousefi, M.; Dadashpour, M.; Hejazi, M.; Hasanzadeh, M.; Behnam, B.; de la Guardia, M.; Shadjou, N.; Mokhtarzadeh, A. Anti-bacterial activity of graphene oxide as a new weapon nanomaterial to combat multidrug-resistance bacteria. Mater. Sci. Eng. C 2017, 74, 568–581. [Google Scholar] [CrossRef]
  136. Cataldo, F.; Da Ros, T. Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes; Springer: Trieste, Italy, 2008; ISBN 9783642253874. [Google Scholar]
  137. Chauhan, S.; Jain, N.; Nagaich, U. Nanodiamonds with powerful ability for drug delivery and biomedical applications: Recent updates on in vivo study and patents. J. Pharm. Anal. 2020, 10, 1–12. [Google Scholar] [CrossRef] [PubMed]
  138. Albrektsson, T.; Johansson, C. Osteoinduction, osteoconduction and osseointegration. Eur. Spine J. 2001, 10, S96–S101. [Google Scholar] [CrossRef] [Green Version]
  139. Zanello, L.P.; Zhao, B.; Hu, H.; Haddon, R.C. Bone cell proliferation on carbon nanotubes. Nano Lett. 2006, 6, 562–567. [Google Scholar] [CrossRef] [PubMed]
  140. Zhijiang, C.; Cong, Z.; Jie, G.; Qing, Z.; Kongyin, Z. Electrospun carboxyl multi-walled carbon nanotubes grafted polyhydroxybutyrate composite nanofibers membrane scaffolds: Preparation, characterization and cytocompatibility. Mater. Sci. Eng. C 2018, 82, 29–40. [Google Scholar] [CrossRef]
  141. Kumar, S.; Raj, S.; Sarkar, K.; Chatterjee, K. Engineering a multi-biofunctional composite using poly(ethylenimine) decorated graphene oxide for bone tissue regeneration. Nanoscale 2016, 8, 6820–6836. [Google Scholar] [CrossRef]
  142. Zanin, H.; Rodrigues, B.V.M.; Ribeiro Neto, W.A.; Bretas, R.E.S.; Da-Silva, N.S.; Marciano, F.R.; Oliveira Lobo, A. High loading of graphene oxide/multi-walled carbon nanotubes into PDLLA: A route towards the design of osteoconductive, bactericidal and non-immunogenic 3D porous scaffolds. Mater. Chem. Phys. 2016, 177, 56–66. [Google Scholar] [CrossRef]
  143. Wang, W.; Caetano, G.; Ambler, W.S.; Blaker, J.J.; Frade, M.A.; Mandal, P.; Diver, C.; Bártolo, P. Enhancing the hydrophilicity and cell attachment of 3D printed PCL/graphene scaffolds for bone tissue engineering. Materials 2016, 9, 992. [Google Scholar] [CrossRef]
  144. Luo, H.; Ao, H.; Peng, M.; Yao, F.; Yang, Z.; Wan, Y. Effect of highly dispersed graphene and graphene oxide in 3D nanofibrous bacterial cellulose scaffold on cell responses: A comparative study. Mater. Chem. Phys. 2019, 235, 121774. [Google Scholar] [CrossRef]
  145. Su, W.; Wang, Z.; Jiang, J.; Liu, X.; Zhao, J.; Zhang, Z. Promoting tendon to bone integration using graphene oxide-doped electrospun poly(lactic-co-glycolic acid) nanofibrous membrane. Int. J. Nanomed. 2019, 14, 1835–1847. [Google Scholar] [CrossRef] [Green Version]
  146. Fang, H.; Luo, C.; Liu, S.; Zhou, M.; Zeng, Y.; Hou, J.; Chen, L.; Mou, S.; Sun, J.; Wang, Z. A biocompatible vascularized graphene oxide (GO)-collagen chamber with osteoinductive and anti-fibrosis effects promotes bone regeneration in vivo. Theranostics 2020, 10, 2759–2772. [Google Scholar] [CrossRef]
  147. Arnold, A.M.; Holt, B.D.; Daneshmandi, L.; Laurencin, C.T.; Sydlik, S.A. Phosphate graphene as an intrinsically osteoinductive scaffold for stem cell-driven bone regeneration. Proc. Natl. Acad. Sci. USA 2019, 116, 4855–4860. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  148. Ramani, D.; Sastry, T.P. Bacterial cellulose-reinforced hydroxyapatite functionalized graphene oxide: A potential osteoinductive composite. Cellulose 2014, 21, 3585–3595. [Google Scholar] [CrossRef]
  149. Vuppaladadium, S.S.R.; Agarwal, T.; Kulanthaivel, S.; Mohanty, B.; Barik, C.S.; Maiti, T.K.; Pal, S.; Pal, K.; Banerjee, I. Silanization improves biocompatibility of graphene oxide. Mater. Sci. Eng. C 2020, 110, 110647. [Google Scholar] [CrossRef]
  150. Elkhenany, H.; Bourdo, S.; Hecht, S.; Donnell, R.; Gerard, D.; Abdelwahed, R.; Lafont, A.; Alghazali, K.; Watanabe, F.; Biris, A.S.; et al. Graphene nanoparticles as osteoinductive and osteoconductive platform for stem cell and bone regeneration. Nanomed. Nanotechnol. Biol. Med. 2017, 13, 2117–2126. [Google Scholar] [CrossRef] [PubMed]
  151. Bacakova, L.; Kopova, I.; Stankova, L.; Liskova, J.; Vacik, J.; Lavrentiev, V.; Kromka, A.; Potocky, S.; Stranska, D. Bone cells in cultures on nanocarbonbased materials for potential bone tissue engineering: A review. Phys. Status Solidi 2014, 211, 2688–2702. [Google Scholar] [CrossRef]
  152. Rašović, I.; Porfyrakis, K. 2.06—Functionalisation of Fullerenes for Biomedical Applications. In Comprehensive Nanoscience and Nanotechnology; Elsevier Inc.: Amsterdam, The Netherlands, 2019; Volume 2, pp. 109–122. ISBN 9780128122952. [Google Scholar]
  153. Brady, M.A.; Renzing, A.; Douglas, T.E.L.; Liu, Q.; Wille, S.; Parizek, M.; Bacakova, L.; Kromka, A.; Jarosova, M.; Godier, G.; et al. Development of composite poly(lactide-co-glycolide)-nanodiamond scaffolds for bone cell growth. J. Nanosci. Nanotechnol. 2015, 15, 1060–1069. [Google Scholar] [CrossRef]
  154. Stankova, L.; Musilkova, J.; Broz, A.; Potocky, S.; Kromka, A.; Kozak, H.; Izak, T.; Artemenko, A.; Stranska, D.; Bacakova, L. Alterations to the adhesion, growth and osteogenic differentiation of human osteoblast-like cells on nanofibrous polylactide scaffolds with diamond nanoparticles. Diam. Relat. Mater. 2019, 97, 107421. [Google Scholar] [CrossRef]
  155. Lalwani, G.; D’Agati, M.; Khan, A.M.; Sitharaman, B. Toxicology of graphene-based nanomaterials. Adv. Drug Deliv. Rev. 2016, 105, 109–144. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  156. Guo, X.; Mei, N. Assessment of the toxic potential of graphene family nanomaterials. J. Food Drug Anal. 2014, 22, 105–115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  157. Muller, J.; Huaux, F.; Moreau, N.; Misson, P.; Heilier, J.F.; Delos, M.; Arras, M.; Fonseca, A.; Nagy, J.B.; Lison, D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 2005, 207, 221–231. [Google Scholar] [CrossRef] [PubMed]
  158. Fraczek, A.; Menaszek, E.; Paluszkiewicz, C.; Blazewicz, M. Comparative in vivo biocompatibility study of single- and multi-wall carbon nanotubes. Acta Biomater. 2008, 4, 1593–1602. [Google Scholar] [CrossRef] [PubMed]
  159. Park, K.H.; Chhowalla, M.; Iqbal, Z.; Sesti, F. Single-walled carbon nanotubes are a new class of ion channel blockers. J. Biol. Chem. 2003, 278, 50212–50216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  160. Zhang, Y.; Ali, S.F.; Dervishi, E.; Xu, Y.; Li, Z.; Casciano, D.; Biris, A.S. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived pc12 cells. ACS Nano 2010, 4, 3181–3186. [Google Scholar] [CrossRef] [PubMed]
  161. Kolodiazhnyi, T.; Pumera, M. Towards an ultrasensitive method for the determination of metal impurities in carbon nanotubes. Small 2008, 4, 1476–1484. [Google Scholar] [CrossRef]
  162. Gholizadeh, S.; Moztarzadeh, F.; Haghighipour, N.; Ghazizadeh, L.; Baghbani, F.; Shokrgozar, M.A.; Allahyari, Z. Preparation and characterization of novel functionalized multiwalled carbon nanotubes/chitosan/β-Glycerophosphate scaffolds for bone tissue engineering. Int. J. Biol. Macromol. 2017, 97, 365–372. [Google Scholar] [CrossRef]
  163. Türk, S.; Altınsoy, I.; Çelebi Efe, G.; Ipek, M.; Özacar, M.; Bindal, C. 3D porous collagen/functionalized multiwalled carbon nanotube/chitosan/hydroxyapatite composite scaffolds for bone tissue engineering. Mater. Sci. Eng. C 2018, 92, 757–768. [Google Scholar] [CrossRef]
  164. Silva, E.; de Vasconcellos, L.M.R.; Rodrigues, B.V.M.; dos Santos, D.M.; Campana-Filho, S.P.; Marciano, F.R.; Webster, T.J.; Lobo, A.O. PDLLA honeycomb-like scaffolds with a high loading of superhydrophilic graphene/multi-walled carbon nanotubes promote osteoblast in vitro functions and guided in vivo bone regeneration. Mater. Sci. Eng. C 2017, 73, 31–39. [Google Scholar] [CrossRef] [Green Version]
  165. Mirmusavi, M.H.; Zadehnajar, P.; Semnani, D.; Karbasi, S.; Fekrat, F.; Heidari, F. Evaluation of physical, mechanical and biological properties of poly 3-hydroxybutyrate-chitosan-multiwalled carbon nanotube/silk nano-micro composite scaffold for cartilage tissue engineering applications. Int. J. Biol. Macromol. 2019, 132, 822–835. [Google Scholar] [CrossRef]
  166. Li, N.; Zhang, X.; Song, Q.; Su, R.; Zhang, Q.; Kong, T.; Liu, L.; Jin, G.; Tang, M.; Cheng, G. The promotion of neurite sprouting and outgrowth of mouse hippocampal cells in culture by graphene substrates. Biomaterials 2011, 32, 9374–9382. [Google Scholar] [CrossRef] [Green Version]
  167. Mallick, M.; Arunachalam, N. Electrophoretic deposited graphene based functional coatings for biocompatibility improvement of Nitinol. Thin Solid Film. 2019, 692, 137616. [Google Scholar] [CrossRef]
  168. Lasocka, I.; Szulc-Dąbrowska, L.; Skibniewski, M.; Skibniewska, E.; Strupinski, W.; Pasternak, I.; Kmieć, H.; Kowalczyk, P. Biocompatibility of pristine graphene monolayer: Scaffold for fibroblasts. Toxicol. Vitr. 2018, 48, 276–285. [Google Scholar] [CrossRef] [PubMed]
  169. Liao, K.H.; Lin, Y.S.; MacOsko, C.W.; Haynes, C.L. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl. Mater. Interfaces 2011, 3, 2607–2615. [Google Scholar] [CrossRef] [PubMed]
  170. Türk, M.; Deliormanli, A. Graphene-containing PCL-coated porous B bioactive glass scaffolds for bone regeneration. Mater. Res. Express 2018, 5, 13. [Google Scholar] [CrossRef]
  171. Yuan, J.; Gao, H.; Sui, J.; Duan, H.; Chen, W.N.; Ching, C.B. Cytotoxicity evaluation of oxidized single-walled carbon nanotubes and graphene oxide on human hepatoma HepG2 cells: An iTRAQ-coupled 2D LC-MS/MS proteome analysis. Toxicol. Sci. 2012, 126, 149–161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  172. Verre, A.F.; Faroni, A.; Iliut, M.; Silva, C.; Muryn, C.; Reid, A.J.; Vijayaraghavan, A. Improving the glial differentiation of human schwann-like adipose-derived stem cells with graphene oxide substrates. Interface Focus 2018, 8, 20180002. [Google Scholar] [CrossRef]
  173. Heidari, M.; Bahrami, S.H.; Ranjbar-Mohammadi, M.; Milan, P.B. Smart electrospun nanofibers containing PCL/gelatin/graphene oxide for application in nerve tissue engineering. Mater. Sci. Eng. C 2019, 103, 109768. [Google Scholar] [CrossRef]
  174. Boga, J.C.; Miguel, S.P.; de Melo-Diogo, D.; Mendonça, A.G.; Louro, R.O.; Correia, I.J. In vitro characterization of 3D printed scaffolds aimed at bone tissue regeneration. Colloids Surfaces B Biointerfaces 2018, 165, 207–218. [Google Scholar] [CrossRef] [PubMed]
  175. Nalvuran, H.; Elçin, A.E.; Elçin, Y.M. Nanofibrous silk fibroin/reduced graphene oxide scaffolds for tissue engineering and cell culture applications. Int. J. Biol. Macromol. 2018, 114, 77–84. [Google Scholar] [CrossRef]
  176. Sivashankari, P.R.; Prabaharan, M. Three-dimensional porous scaffolds based on agarose/chitosan/graphene oxide composite for tissue engineering. Int. J. Biol. Macromol. 2020, 146, 222–231. [Google Scholar] [CrossRef]
  177. Singla, R.; Sharma, C.; Shukla, A.K.; Acharya, A. Toxicity Concerns of Therapeutic Nanomaterials. J. Nanosci. Nanotechnol. 2019, 19, 1889–1907. [Google Scholar] [CrossRef]
  178. Sayes, C.M.; Fortner, J.D.; Guo, W.; Lyon, D.; Boyd, A.M.; Ausman, K.D.; Tao, Y.J.; Sitharaman, B.; Wilson, L.J.; Hughes, J.B.; et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 2004, 4, 1881–1887. [Google Scholar] [CrossRef]
  179. Biby, T.E.; Prajitha, N.; Ashtami, J.; Sakthikumar, D.; Maekawa, T.; Mohanan, P.V. Toxicity of dextran stabilized fullerene C60 against C6 Glial cells. Brain Res. Bull. 2020, 155, 191–201. [Google Scholar] [CrossRef] [PubMed]
  180. Gharbi, N.; Pressac, M.; Hadchouel, M.; Szwarc, H.; Wilson, S.R. Fullerene is an in vivo Powerful Antioxidant With no Acute or Sub-acute Toxicity. Nano Lett. 2005, 5, 2578–2585. [Google Scholar] [CrossRef] [PubMed]
  181. Houshyar, S.; Kumar, G.S.; Rifai, A.; Tran, N.; Nayak, R.; Shanks, R.A.; Padhye, R.; Fox, K.; Bhattacharyya, A. Nanodiamond/poly-ε-caprolactone nanofibrous scaffold for wound management. Mater. Sci. Eng. C 2019, 100, 378–387. [Google Scholar] [CrossRef]
  182. Houshyar, S.; Sarker, A.; Jadhav, A.; Kumar, G.S.; Bhattacharyya, A.; Nayak, R.; Shanks, R.A.; Saha, T.; Rifai, A.; Padhye, R.; et al. Polypropylene-nanodiamond composite for hernia mesh. Mater. Sci. Eng. C 2020, 111, 110780. [Google Scholar] [CrossRef]
  183. Nunes-Pereira, J.; Silva, A.R.; Ribeiro, C.; Carabineiro, S.A.C.; Buijnsters, J.G.; Lanceros-Méndez, S. Nanodiamonds/poly(vinylidene fluoride) composites for tissue engineering applications. Compos. Part B Eng. 2017, 111, 37–44. [Google Scholar] [CrossRef]
  184. Schrand, A.M.; Huang, H.; Carlson, C.; Schlager, J.J.; Osawa, E.; Hussain, S.M.; Dai, L. Are diamond nanoparticles cytotoxic? J. Phys. Chem. B 2007, 111, 2–7. [Google Scholar] [CrossRef]
  185. Martín, C.; Kostarelos, K.; Prato, M.; Bianco, A. Biocompatibility and biodegradability of 2D materials: Graphene and beyond. Chem. Commun. 2019, 55, 5540–5546. [Google Scholar] [CrossRef]
  186. Sánchez-González, S.; Diban, N.; Urtiaga, A. Hydrolytic degradation and mechanical stability of poly(ε-Caprolactone)/reduced graphene oxide membranes as scaffolds for in vitro neural tissue regeneration. Membranes 2018, 8, 12. [Google Scholar] [CrossRef] [Green Version]
  187. Murray, E.; Thompson, B.C.; Sayyar, S.; Wallace, G.G. Enzymatic degradation of graphene/polycaprolactone materials for tissue engineering. Polym. Degrad. Stab. 2015, 111, 71–77. [Google Scholar] [CrossRef]
  188. Olad, A.; Hagh, H.B.K. Graphene oxide and amin-modified graphene oxide incorporated chitosan-gelatin scaffolds as promising materials for tissue engineering. Compos. Part B Eng. 2019, 162, 692–702. [Google Scholar] [CrossRef]
  189. Sivashankari, P.R.; Moorthi, A.; Abudhahir, K.M.; Prabaharan, M. Preparation and characterization of three-dimensional scaffolds based on hydroxypropyl chitosan-graft-graphene oxide. Int. J. Biol. Macromol. 2018, 110, 522–530. [Google Scholar] [CrossRef] [PubMed]
  190. Unnithan, A.R.; Sasikala, A.R.K.; Park, C.H.; Kim, C.S. A unique scaffold for bone tissue engineering: An osteogenic combination of graphene oxide–hyaluronic acid–chitosan with simvastatin. J. Ind. Eng. Chem. 2017, 46, 182–191. [Google Scholar] [CrossRef]
  191. Saravanan, S.; Chawla, A.; Vairamani, M.; Sastry, T.P.; Subramanian, K.S.; Selvamurugan, N. Scaffolds containing chitosan, gelatin and graphene oxide for bone tissue regeneration in vitro and in vivo. Int. J. Biol. Macromol. 2017, 104, 1975–1985. [Google Scholar] [CrossRef] [PubMed]
  192. Pandele, A.M.; Ionita, M.; Crica, L.; Vasile, E.; Iovu, H. Novel Chitosan-poly(vinyl alcohol)/graphene oxide biocomposites 3D porous scaffolds. Compos. Part B Eng. 2017, 126, 81–87. [Google Scholar] [CrossRef]
  193. Joddar, B.; Garcia, E.; Casas, A.; Stewart, C.M. Development of functionalized multi-walled carbon-nanotube-based alginate hydrogels for enabling biomimetic technologies. Sci. Rep. 2016, 6, 32456. [Google Scholar] [CrossRef]
  194. Schmutz, M.; Borges, O.; Jesus, S.; Borchard, G.; Perale, G.; Zinn, M.; Sips, Ä.A.; Soeteman-Hernandez, L.G.; Wick, P.; Som, C. A Methodological Safe-by-Design Approach for the Development of Nanomedicines. Front. Bioeng. Biotechnol. 2020, 8, 1–7. [Google Scholar] [CrossRef]
  195. Kuboki, Y.; Takita, H.; Kobayashi, D.; Tsuruga, E.; Inoue, M.; Murata, M.; Nagai, N.; Dohi, Y.; Ohgushi, H. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: Topology of osteogenesis. J. Biomed. Mater. Res. 1998, 39, 190–199. [Google Scholar] [CrossRef]
  196. Conrad, T.L.; Roeder, R.K. Effects of porogen morphology on the architecture, permeability, and mechanical properties of hydroxyapatite whisker reinforced polyetheretherketone scaffolds. J. Mech. Behav. Biomed. Mater. 2020, 106, 103730. [Google Scholar] [CrossRef]
  197. Karageorgiou, V.; Kaplan, D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005, 26, 5474–5491. [Google Scholar] [CrossRef]
  198. Murphy, C.M.; Haugh, M.G.; O’Brien, F.J. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010, 31, 461–466. [Google Scholar] [CrossRef]
  199. Abbasi, N.; Hamlet, S.; Love, R.M.; Nguyen, N.T. Porous scaffolds for bone regeneration. J. Sci. Adv. Mater. Devices 2020. [Google Scholar] [CrossRef]
  200. Hulbert, S.F.; Young, F.A.; Mathews, R.S.; Klawitter, J.J.; Talbert, C.D.; Stelling, F.H. Potential of ceramic materials as permanently implantable skeletal prostheses. J. Biomed. Mater. Res. 1970, 4, 433–456. [Google Scholar] [CrossRef] [PubMed]
  201. Cantore, S.; Crincoli, V.; Boccaccio, A.; Uva, A.E.; Fiorentino, M.; Monno, G.; Bollero, P.; Derla, C.; Fabiano, F.; Ballini, A.; et al. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds. Endocr. Metab. Immune Disord.-Drug Targets 2018, 18, 466–469. [Google Scholar] [CrossRef] [PubMed]
  202. Ballini, A.; Boccaccio, A.; Saini, R.; Van Pham, P.; Tatullo, M. Dental-derived stem cells and their secretome and interactions with Bioscaffolds/Biomaterials in regenerative medicine: From the in vitro research to translational applications. Stem Cells Int. 2017, 2017, 15–18. [Google Scholar] [CrossRef] [PubMed]
  203. Chang, G.W.; Tseng, C.L.; Tzeng, Y.S.; Chen, T.M.; Fang, H.W. An in vivo evaluation of a novel malleable composite scaffold (polypropylene carbonate/ poly(D-lactic acid) /tricalcium phosphate elastic composites) for bone defect repair. J. Taiwan Inst. Chem. Eng. 2017, 80, 813–819. [Google Scholar] [CrossRef]
  204. Choi, J.; Kim, K.; Kim, T.; Liu, G.; Bar-Shir, A.; Hyeon, T.; McMahon, M.T.; Bulte, J.W.M.; Fisher, J.P.; Gilad, A.A. Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds. J. Control. Release 2011, 156, 239–245. [Google Scholar] [CrossRef] [Green Version]
  205. Świętek, M.; Brož, A.; Tarasiuk, J.; Wroński, S.; Tokarz, W.; Kozieł, A.; Błażewicz, M.; Bačáková, L. Carbon nanotube/iron oxide hybrid particles and their PCL-based 3D composites for potential bone regeneration. Mater. Sci. Eng. C 2019, 104, 109913. [Google Scholar] [CrossRef]
  206. Salerno, A.; Leonardi, A.B.; Pedram, P.; Di Maio, E.; Fanovich, M.A.; Netti, P.A. Tuning the three-dimensional architecture of supercritical CO2 foamed PCL scaffolds by a novel mould patterning approach. Mater. Sci. Eng. C 2020, 109, 110518. [Google Scholar] [CrossRef]
  207. Manavitehrani, I.; Le, T.Y.L.; Daly, S.; Wang, Y.; Maitz, P.K.; Schindeler, A.; Dehghani, F. Formation of porous biodegradable scaffolds based on poly(propylene carbonate) using gas foaming technology. Mater. Sci. Eng. C 2019, 96, 824–830. [Google Scholar] [CrossRef]
  208. Naderi, P.; Zarei, M.; Karbasi, S.; Salehi, H. Evaluation of the effects of keratin on physical, mechanical and biological properties of poly (3-hydroxybutyrate) electrospun scaffold: Potential application in bone tissue engineering. Eur. Polym. J. 2020, 124, 109502. [Google Scholar] [CrossRef]
  209. Barati, G.; Rahmani, A.; Nadri, S. In vitro differentiation of conjunctiva mesenchymal stem cells into insulin producing cells on natural and synthetic electrospun scaffolds. Biologicals 2019, 62, 33–38. [Google Scholar] [CrossRef] [PubMed]
  210. Fadaie, M.; Mirzaei, E.; Geramizadeh, B.; Asvar, Z. Incorporation of nanofibrillated chitosan into electrospun PCL nanofibers makes scaffolds with enhanced mechanical and biological properties. Carbohydr. Polym. 2018, 199, 628–640. [Google Scholar] [CrossRef] [PubMed]
  211. Fereshteh, Z.; Fathi, M.; Bagri, A.; Boccaccini, A.R. Preparation and characterization of aligned porous PCL/zein scaffolds as drug delivery systems via improved unidirectional freeze-drying method. Mater. Sci. Eng. C 2016, 68, 613–622. [Google Scholar] [CrossRef]
  212. Ge, Z.; Jin, Z.; Cao, T. Manufacture of degradable polymeric scaffolds for bone regeneration. Biomed. Mater. 2008, 3, 022001. [Google Scholar] [CrossRef]
  213. Ghorbani, F.; Li, D.; Ni, S.; Zhou, Y.; Yu, B. 3D printing of acellular scaffolds for bone defect regeneration: A review. Mater. Today Commun. 2020, 22, 100979. [Google Scholar] [CrossRef]
  214. Du, X.; Fu, S.; Zhu, Y. 3D printing of ceramic-based scaffolds for bone tissue engineering: An overview. J. Mater. Chem. B 2018, 6, 4397–4412. [Google Scholar] [CrossRef]
  215. Zamani, Y.; Amoabediny, G.; Mohammadi, J.; Seddiqi, H.; Helder, M.N.; Zandieh-Doulabi, B.; Klein-Nulend, J.; Koolstra, J.H. 3D-printed poly(Ɛ-caprolactone) scaffold with gradient mechanical properties according to force distribution in the mandible for mandibular bone tissue engineering. J. Mech. Behav. Biomed. Mater. 2020, 104, 103638. [Google Scholar] [CrossRef]
  216. Ronca, D.; Langella, F.; Chierchia, M.; D’Amora, U.; Russo, T.; Domingos, M.; Gloria, A.; Bartolo, P.; Ambrosio, L. Bone tissue engineering: 3D PCL-based nanocomposite scaffolds with tailored properties. Procedia CIRP 2016, 49, 51–54. [Google Scholar] [CrossRef]
  217. ISO/ASTM52900-15. Standard Terminology for Additive Manufacturing—General Principles—Terminology; ASTM International: West Conshohocken, PA, USA, 2015. [Google Scholar]
  218. Qu, H. Additive manufacturing for bone tissue engineering scaffolds. Mater. Today Commun. 2020, 101024. [Google Scholar] [CrossRef]
  219. Singamneni, S.; Velu, R.; Behera, M.P.; Scott, S.; Brorens, P.; Harland, D.; Gerrard, J. Selective laser sintering responses of keratin-based bio-polymer composites. Mater. Des. 2019, 183, 108087. [Google Scholar] [CrossRef]
  220. Bose, S.; Ke, D.; Sahasrabudhe, H.; Bandyopadhyay, A. Additive manufacturing of biomaterials. Prog. Mater. Sci. 2018, 93, 45–111. [Google Scholar] [CrossRef] [PubMed]
  221. Hull, C.W. Apparatus for Production of Three-Dimensional Objects by Stereolithography. U.S. Patent 4,575,330, 19 December 1989. [Google Scholar]
  222. Riley, D.J.; Bavastrello, V.; Covani, U.; Barone, A.; Nicolini, C. An in-vitro study of the sterilization of titanium dental implants using low intensity UV-radiation. Dent. Mater. 2005, 21, 756–760. [Google Scholar] [CrossRef] [PubMed]
  223. Melchels, F.P.W.; Feijen, J.; Grijpma, D.W. A poly(D,L-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials 2009, 30, 3801–3809. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  224. Cooke, M.N.; Fisher, J.P.; Dean, D.; Rimnac, C.; Mikos, A.G. Use of Stereolithography to Manufacture Critical-Sized 3D Biodegradable Scaffolds for Bone Ingrowth. J. Biomed. Mater. Res. Part B Appl. Biomater. 2003, 64B, 65–69. [Google Scholar] [CrossRef] [PubMed]
  225. Gnanasekaran, K.; Heijmans, T.; van Bennekom, S.; Woldhuis, H.; Wijnia, S.; de With, G.; Friedrich, H. 3D printing of CNT- and graphene-based conductive polymer nanocomposites by fused deposition modeling. Appl. Mater. Today 2017, 9, 21–28. [Google Scholar] [CrossRef]
  226. Wei, X.; Li, D.; Jiang, W.; Gu, Z.; Wang, X.; Zhang, Z.; Sun, Z. 3D Printable Graphene Composite. Sci. Rep. 2015, 5, 11181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  227. Dul, S.; Fambri, L.; Pegoretti, A. Fused deposition modeling with ABS-graphene nanocomposites. Compos. Part A Appl. Sci. Manuf. 2016, 85, 181–191. [Google Scholar] [CrossRef]
  228. Savaris, M.; dos Santos, V.; Brandalise, R.N. Influence of different sterilization processes on the properties of commercial poly(lactic acid). Mater. Sci. Eng. C 2016, 69, 661–667. [Google Scholar] [CrossRef]
  229. Shi, G.; Lowe, S.E.; Teo, A.J.T.; Dinh, T.K.; Tan, S.H.; Qin, J.; Zhang, Y.; Zhong, Y.L.; Zhao, H. A versatile PDMS submicrobead/graphene oxide nanocomposite ink for the direct ink writing of wearable micron-scale tactile sensors. Appl. Mater. Today 2019, 16, 482–492. [Google Scholar] [CrossRef]
  230. Chizari, K.; Daoud, M.A.; Ravindran, A.R.; Therriault, D. 3D printing of highly conductive nanocomposites for the functional optimization of liquid sensors. Small 2016, 12, 6076–6082. [Google Scholar] [CrossRef] [PubMed]
  231. Zhang, Y.; Hao, L.; Savalani, M.M.; Harris, R.A.; Tanner, K.E. Characterization and dynamic mechanical analysis of selective laser sintered hydroxyapatite-filled polymeric composites. J. Biomed. Mater. Res. Part B Appl. Biomater. 2008, 86A, 607–616. [Google Scholar] [CrossRef] [PubMed]
  232. Chunze, Y.; Yusheng, S.; Jinsong, Y.; Jinhui, L. A nanosilica/nylon-12 composite powder for selective laser sintering. J. Reinf. Plast. Compos. 2009, 28, 2889–2902. [Google Scholar] [CrossRef]
  233. Chung, H.; Das, S. Functionally graded Nylon-11/silica nanocomposites produced by selective laser sintering. Mater. Sci. Eng. A 2008, 487, 251–257. [Google Scholar] [CrossRef]
  234. Valino, A.D.; Dizon, J.R.C.; Espera, A.H.; Chen, Q.; Messman, J.; Advincula, R.C. Advances in 3D printing of thermoplastic polymer composites and nanocomposites. Prog. Polym. Sci. 2019, 98, 101162. [Google Scholar] [CrossRef]
  235. Drummer, D.; Medina-Hernández, M.; Drexler, M.; Wudy, K. Polymer powder production for laser melting through immiscible blends. Procedia Eng. 2015, 102, 1918–1925. [Google Scholar] [CrossRef] [Green Version]
  236. Lee, S.-J.; Zhu, W.; Nowicki, M.; Lee, G.; Heo, D.N.; Kim, J.; Zuo, Y.Y.; Zhang, L.G. 3D printing nano conductive multi-walled carbon nanotube scaffolds for nerve regeneration. J. Neural Eng. 2018, 15, 016018. [Google Scholar] [CrossRef]
  237. Sciancalepore, C.; Moroni, F.; Messori, M.; Bondioli, F. Acrylate-based silver nanocomposite by simultaneous polymerization–reduction approach via 3D stereolithography. Compos. Commun. 2017, 6, 11–16. [Google Scholar] [CrossRef]
  238. Feng, Z.; Li, Y.; Hao, L.; Yang, Y.; Tang, T.; Tang, D.; Xiong, W. Graphene-Reinforced Biodegradable Resin Composites for Stereolithographic 3D Printing of Bone Structure Scaffolds. J. Nanomater. 2019, 1–13. [Google Scholar] [CrossRef] [Green Version]
  239. Dizon, J.R.C.; Chen, Q.; Valino, A.D.; Advincula, R.C. Thermo-mechanical and swelling properties of three-dimensional-printed poly (ethylene glycol) diacrylate/silica nanocomposites. MRS Commun. 2018, 9, 209–217. [Google Scholar] [CrossRef]
  240. Feng, Z.; Li, Y.; Xin, C.; Tang, D.; Xiong, W.; Zhang, H. Fabrication of Graphene-Reinforced Nanocomposites with Improved Fracture Toughness in Net Shape for Complex 3D Structures via Digital Light Processing. J. Carbon Res. 2019, 5, 25. [Google Scholar] [CrossRef] [Green Version]
  241. Sofi, H.S.; Ashraf, R.; Beigh, M.A.; Sheikh, F.A. Scaffolds Fabricated from Natural Polymers/Composites by Electrospinning for Bone Tissue Regeneration. Adv. Exp. Med. Biol. 2018, 1078, 49–78. [Google Scholar] [CrossRef] [PubMed]
  242. Subuki, I.; Adnan, N.; Sharudin, R.W. Biodegradable Scaffold of Natural Polymer and Hydroxyapatite for Bone Tissue Engineering: A Short Review. In AIP Conference Proceedings; AIP Publishing LLC.: Melville, NY, USA, 2018; Volume 2031, p. 020019. [Google Scholar] [CrossRef]
  243. Chocholata, P.; Kulda, V.; Babuska, V. Fabrication of scaffolds for bone-tissue regeneration. Materials 2019, 12, 568. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  244. Guo, B.; Ma, P.X. Synthetic biodegradable functional polymers for tissue engineering: A brief review. Sci. China Chem. 2014, 57, 490–500. [Google Scholar] [CrossRef] [PubMed]
  245. Migliaresi, C.; Motta, A.; Rojo, L.; Vázquez, B.; Román, J. Biomaterials for Scaffolds: Synthetic Polymers. In Scaffolds for Tissue Engineering; Jenny Stanford Publishing: Singapore, 2014; pp. 263–300. ISBN 9789814463201. [Google Scholar]
  246. Chartrain, N.A.; Williams, C.B.; Whittington, A.R. A review on fabricating tissue scaffolds using vat photopolymerization. Acta Biomater. 2018, 74, 90–111. [Google Scholar] [CrossRef]
  247. George, A.; Sanjay, M.R.; Srisuk, R.; Parameswaranpillai, J.; Siengchin, S. A comprehensive review on chemical properties and applications of biopolymers and their composites. Int. J. Biol. Macromol. 2020, 154, 329–338. [Google Scholar] [CrossRef]
  248. Wen, Y.; Xun, S.; Haoye, M.; Baichuan, S.; Peng, C.; Xuejian, L.; Kaihong, Z.; Xuan, Y.; Jiang, P.; Shibi, L. 3D printed porous ceramic scaffolds for bone tissue engineering: A review. Biomater. Sci. 2017, 5, 1690–1698. [Google Scholar] [CrossRef]
  249. Jodati, H.; Yılmaz, B.; Evis, Z. A review of bioceramic porous scaffolds for hard tissue applications: Effects of structural features. Ceram. Int. 2020, in press. [Google Scholar] [CrossRef]
  250. Tanaka, T.; Komaki, H.; Chazono, M.; Kitasato, S.; Kakuta, A.; Akiyama, S.; Marumo, K. Basic research and clinical application of Beta-tricalcium phosphate (β-TCP). Morphologie 2017, 101, 164–172. [Google Scholar] [CrossRef]
  251. Lin, K.; Chang, J. Structure and Properties of Hydroxyapatite for Biomedical Applications; Elsevier Inc.: Amsterdam, The Netherlands, 2015; ISBN 9781782420330. [Google Scholar]
  252. Wu, C.; Chang, J. Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics. J. Biomed. Mater. Res. Part B Appl. Biomater. 2007, 83, 153–160. [Google Scholar] [CrossRef]
  253. Li, J.; Liu, X.; Crook, J.M.; Wallace, G.G. 3D graphene-containing structures for tissue engineering. Mater. Today Chem. 2019, 14, 100199. [Google Scholar] [CrossRef]
  254. Xie, H.; Cao, T.; Rodríguez-Lozano, F.J.; Luong-Van, E.K.; Rosa, V. Graphene for the development of the next-generation of biocomposites for dental and medical applications. Dent. Mater. 2017, 33, 765–774. [Google Scholar] [CrossRef]
  255. Szymczyk-Ziółkowska, P.; Łabowska, M.B.; Detyna, J.; Michalak, I.; Gruber, P. A review of fabrication polymer scaffolds for biomedical applications using additive manufacturing techniques. Biocybern. Biomed. Eng. 2020, 40, 624–638. [Google Scholar] [CrossRef]
  256. Hassan, M.; Dave, K.; Chandrawati, R.; Dehghani, F.; Gomes, V.G. 3D printing of biopolymer nanocomposites for tissue engineering: Nanomaterials, processing and structure-function relation. Eur. Polym. J. 2019, 121, 109340. [Google Scholar] [CrossRef]
  257. Wang, C.; Huang, W.; Zhou, Y.; He, L.; He, Z.; Chen, Z.; He, X.; Tian, S.; Liao, J.; Lu, B.; et al. 3D printing of bone tissue engineering scaffolds. Bioact. Mater. 2020, 5, 82–91. [Google Scholar] [CrossRef] [PubMed]
  258. Dwivedi, R.; Kumar, S.; Pandey, R.; Mahajan, A.; Nandana, D.; Katti, D.S.; Mehrotra, D. Polycaprolactone as biomaterial for bone scaffolds: Review of literature. J. Oral Biol. Craniofacial Res. 2020, 10, 381–388. [Google Scholar] [CrossRef]
  259. Nikolova, M.P.; Chavali, M.S. Recent advances in biomaterials for 3D scaffolds: A review. Bioact. Mater. 2019, 4, 271–292. [Google Scholar] [CrossRef]
  260. Melo, S.F.; Neves, S.C.; Pereira, A.T.; Borges, I.; Granja, P.L.; Magalhães, F.D.; Gonçalves, I.C. Incorporation of graphene oxide into poly(ε-caprolactone) 3D printed fibrous scaffolds improves their antimicrobial properties. Mater. Sci. Eng. C 2020, 109, 110537. [Google Scholar] [CrossRef]
  261. Unagolla, J.M.; Jayasuriya, A.C. Enhanced cell functions on graphene oxide incorporated 3D printed polycaprolactone scaffolds. Mater. Sci. Eng. C 2019, 102, 1–11. [Google Scholar] [CrossRef]
  262. Belaid, H.; Nagarajan, S.; Teyssier, C.; Barou, C.; Barés, J.; Balme, S.; Bechelany, M. Development of new biocompatible 3D printed graphene oxide-based scaffolds. Mater. Sci. Eng. C 2020, 110, 110595. [Google Scholar] [CrossRef]
  263. Wang, W.; Huang, B.; Byun, J.J.; Bártolo, P. Assessment of PCL/carbon material scaffolds for bone regeneration. J. Mech. Behav. Biomed. Mater. 2019, 93, 52–60. [Google Scholar] [CrossRef] [PubMed]
  264. Sayyar, S.; Bjorninen, M.; Haimi, S.; Miettinen, S.; Gilmore, K.; Grijpma, D.; Wallace, G. UV cross-linkable graphene/poly(trimethylene carbonate) composites for 3D printing of electrically conductive scaffolds. ACS Appl. Mater. Interfaces 2016, 8, 31916–31925. [Google Scholar] [CrossRef] [PubMed]
  265. Alam, F.; Varadarajan, K.M.; Kumar, S. 3D printed polylactic acid nanocomposite scaffolds for tissue engineering applications. Polym. Test. 2020, 81, 106203. [Google Scholar] [CrossRef]
  266. Huang, B.; Vyas, C.; Roberts, I.; Poutrel, Q.A.; Chiang, W.H.; Blaker, J.J.; Huang, Z.; Bártolo, P. Fabrication and characterisation of 3D printed MWCNT composite porous scaffolds for bone regeneration. Mater. Sci. Eng. C 2019, 98, 266–278. [Google Scholar] [CrossRef] [PubMed]
  267. Huang, B.; Vyas, C.; Byun, J.J.; El-Newehy, M.; Huang, Z.; Bártolo, P. Aligned multi-walled carbon nanotubes with nanohydroxyapatite in a 3D printed polycaprolactone scaffold stimulates osteogenic differentiation. Mater. Sci. Eng. C 2020, 108, 110374. [Google Scholar] [CrossRef] [PubMed]
  268. Jakus, A.E.; Secor, E.B.; Rutz, A.L.; Jordan, S.W.; Hersam, M.C.; Shah, R.N. Three-dimensional printing of high-content graphene scaffolds for electronic and biomedical applications. ACS Nano 2015, 9, 4636–4648. [Google Scholar] [CrossRef] [PubMed]
  269. Feng, P.; Jia, J.; Peng, S.; Yang, W.; Bin, S.; Shuai, C. Graphene oxide-driven interfacial coupling in laser 3D printed PEEK/PVA scaffolds for bone regeneration. Virtual Phys. Prototyp. 2020. [Google Scholar] [CrossRef]
  270. Shuai, C.; Yang, Y.; Feng, P.; Peng, S.; Guo, W.; Min, A.; Gao, C. A multi-scale porous scaffold fabricated by a combined additive manufacturing and chemical etching process for bone tissue engineering. Int. J. Bioprinting 2018, 4, 1–12. [Google Scholar] [CrossRef]
  271. Shuai, C.; Guo, W.; Wu, P.; Yang, W.; Hu, S.; Xia, Y.; Feng, P. A graphene oxide-Ag co-dispersing nanosystem: Dual synergistic effects on antibacterial activities and mechanical properties of polymer scaffolds. Chem. Eng. J. 2018, 347, 322–333. [Google Scholar] [CrossRef]
  272. Feng, P.; Kong, Y.; Yu, L.; Li, Y.; Gao, C.; Peng, S.; Pan, H.; Zhao, Z.; Shuai, C. Molybdenum disulfide nanosheets embedded with nanodiamond particles: Co-dispersion nanostructures as reinforcements for polymer scaffolds. Appl. Mater. Today 2019, 17, 216–226. [Google Scholar] [CrossRef]
  273. Jakus, A.E.; Shah, R.N. Multi and mixed 3D-printing of graphene-hydroxyapatite hybrid materials for complex tissue engineering. J. Biomed. Mater. Res. Part A 2016, 4, 274–283. [Google Scholar] [CrossRef] [PubMed]
  274. Gonçalves, E.M.; Oliveira, F.J.; Silva, R.F.; Neto, M.A.; Fernandes, M.H.; Amaral, M.; Vallet-Regí, M.; Vila, M. Three-dimensional printed PCL-hydroxyapatite scaffolds filled with CNTs for bone cell growth stimulation. J. Biomed. Mater. Res. Part B Appl. Biomater. 2016, 104, 1210–1219. [Google Scholar] [CrossRef] [PubMed]
  275. Shuai, C.; Gao, C.; Feng, P.; Peng, S. Graphene-reinforced mechanical properties of calcium silicate scaffolds by laser sintering. RSC Adv. 2014, 4, 12782–12788. [Google Scholar] [CrossRef]
  276. Shuai, C.; Liu, T.; Gao, C.; Feng, P.; Xiao, T.; Yu, K.; Peng, S. Mechanical and structural characterization of diopside scaffolds reinforced with graphene. J. Alloys Compd. 2016, 655, 86–92. [Google Scholar] [CrossRef]
  277. Liu, J.; Gao, C.; Feng, P.; Xiao, T.; Shuai, C.; Peng, S. A bioactive glass nanocomposite scaffold toughed by multi-wall carbon nanotubes for tissue engineering. J. Ceram. Soc. Jpn. 2015, 123, 485–491. [Google Scholar] [CrossRef] [Green Version]
  278. Shuai, C.; Liu, T.; Gao, C.; Feng, P.; Peng, S. Mechanical reinforcement of diopside bone scaffolds with carbon nanotubes. Int. J. Mol. Sci. 2014, 15, 19319–19329. [Google Scholar] [CrossRef] [Green Version]
  279. Lin, L.L.; Shen, Y.Y.; Zhang, J.F.; Fang, M.L. Microstructure and mechanical properties analysis of β-tricalcium phosphate/carbon nanotubes scaffold based on rapid prototyping. J. Shanghai Univ. 2009, 13, 349–351. [Google Scholar] [CrossRef]
  280. Liu, T.; Wu, P.; Gao, C.; Feng, P.; Xiao, T.; Deng, Y.; Shuai, C.; Peng, S. Synergistic effect of carbon nanotubes and graphene on diopside scaffolds. Biomed Res. Int. 2016, 2016, 7090635. [Google Scholar] [CrossRef] [Green Version]
  281. Hollister, S.J.; Flanagan, C.L.; Zopf, D.A.; Morrison, R.J.; Nasser, H.; Patel, J.J.; Ebramzadeh, E.; Sangiorgio, S.N.; Wheeler, M.B.; Green, G.E. Design Control for Clinical Translation of 3D Printed Modular Scaffolds. Ann. Biomed. Eng. 2015, 43, 774–786. [Google Scholar] [CrossRef]
  282. Shan Wong, Y.; Yong Tay, C.; Wen, F.; S Venkatraman, S.; Poh Tan, L. Engineered Polymeric Biomaterials for Tissue Engineering. Curr. Tissue Eng. 2012, 1, 41–53. [Google Scholar] [CrossRef]
  283. Yuan, X.; Zhang, X.; Sun, L.; Wei, Y.; Wei, X. Cellular toxicity and immunological effects of carbon-based nanomaterials. Part. Fibre Toxicol. 2019, 16, 18. [Google Scholar] [CrossRef] [PubMed]
  284. Bullock, C.J.; Bussy, C. Biocompatibility considerations in the design of graphene biomedical materials. Adv. Mater. Interfaces 2019, 6, 1900229. [Google Scholar] [CrossRef]
  285. Wang, W.; Yeung, K.W.K. Bone grafts and biomaterials substitutes for bone defect repair: A review. Bioact. Mater. 2017, 2, 224–247. [Google Scholar] [CrossRef] [PubMed]
  286. Fini, M.; Giardino, R. In vitro and in vivo tests for the biological evaluation of candidate orthopedic materials: Benefits and limits. J. Appl. Biomater. Biomech. 2003, 1, 155–163. [Google Scholar] [CrossRef]
  287. Dziki, J.L.; Badylak, S.F. Acellular biologic scaffolds in regenerative medicine: Unacceptable variability with acceptable results. Regen. Eng. Transl. Med. 2019, 5, 414–419. [Google Scholar] [CrossRef]
  288. Webber, M.J.; Khan, O.F.; Sydlik, S.A.; Tang, B.C.; Langer, R. A perspective on the clinical translation of scaffolds for tissue engineering. Ann. Biomed. Eng. 2015, 43, 641–656. [Google Scholar] [CrossRef] [Green Version]
  289. Van Norman, G.A. Drugs, devices, and the FDA: Part 2: An overview of approval processes: FDA approval of medical devices. JACC Basic Transl. Sci. 2016, 1, 277–287. [Google Scholar] [CrossRef] [Green Version]
  290. Hollister, S.J.; Murphy, W.L. Scaffold translation: Barriers between concept and clinic. Tissue Eng. Part B Rev. 2011, 17, 459–474. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Bone defect healing: from self-healing to bone tissue engineering.
Figure 1. Bone defect healing: from self-healing to bone tissue engineering.
Materials 13 05083 g001
Figure 2. Inhibition of crack propagation by graphene in bioactive glass scaffold by different mechanisms: (ac) crack deflection, crack bridging and graphene pull-out; (d) termination of crack growth at the crack tip [73].
Figure 2. Inhibition of crack propagation by graphene in bioactive glass scaffold by different mechanisms: (ac) crack deflection, crack bridging and graphene pull-out; (d) termination of crack growth at the crack tip [73].
Materials 13 05083 g002
Figure 3. Carbon-based nanomaterials (modified from [117]).
Figure 3. Carbon-based nanomaterials (modified from [117]).
Materials 13 05083 g003
Figure 4. Live (green) and dead (red) MC3T3-E1 cells seeded on poly ε-caprolactone (PCL)-coated bioactive glass with different percentages of graphene. (ac) Without graphene, (df) 1 wt.% graphene (G), (gi) 3 wt.% G, (jl) 5 wt.% G and (mp) 10 wt.% G. After 7 days, the density of cells on G-containing scaffolds was higher than without G. However, after 14 days of incubation, a decrease in cell viability is observed due to the presence of G (reprinted from [170] with permission from Elsevier).
Figure 4. Live (green) and dead (red) MC3T3-E1 cells seeded on poly ε-caprolactone (PCL)-coated bioactive glass with different percentages of graphene. (ac) Without graphene, (df) 1 wt.% graphene (G), (gi) 3 wt.% G, (jl) 5 wt.% G and (mp) 10 wt.% G. After 7 days, the density of cells on G-containing scaffolds was higher than without G. However, after 14 days of incubation, a decrease in cell viability is observed due to the presence of G (reprinted from [170] with permission from Elsevier).
Materials 13 05083 g004
Figure 5. MC3T3 osteoblasts viability and proliferation measured by fluorescence intensity for G-containing PCL scaffolds. The higher the G content, the higher the cell proliferation rate. (*) Statistical analysis difference p < 0.05; (**) p < 0.01; (***) p < 0.001 (reprinted from [93], with permission from Elsevier).
Figure 5. MC3T3 osteoblasts viability and proliferation measured by fluorescence intensity for G-containing PCL scaffolds. The higher the G content, the higher the cell proliferation rate. (*) Statistical analysis difference p < 0.05; (**) p < 0.01; (***) p < 0.001 (reprinted from [93], with permission from Elsevier).
Materials 13 05083 g005
Figure 6. Effect of mean pore size of collagen-glycosaminoglycan scaffolds on MC3T3-E1 cell attachment and proliferation at different time points: at 24 h (A), at 48 h (B) and 7 days (C). The relation between mean pore size and cell response is non-linear (reprinted from [198], with permission from Elsevier).
Figure 6. Effect of mean pore size of collagen-glycosaminoglycan scaffolds on MC3T3-E1 cell attachment and proliferation at different time points: at 24 h (A), at 48 h (B) and 7 days (C). The relation between mean pore size and cell response is non-linear (reprinted from [198], with permission from Elsevier).
Materials 13 05083 g006
Figure 7. SEM images of PCL scaffolds with different percentages of Graphene oxide (GO), manufactured by Fused Deposition Modeling (FDM). Surface roughness and irregularity increased with the addition of GO. The average diameter of the fibres did not change with GO (reprinted from [260], with permission from Elsevier).
Figure 7. SEM images of PCL scaffolds with different percentages of Graphene oxide (GO), manufactured by Fused Deposition Modeling (FDM). Surface roughness and irregularity increased with the addition of GO. The average diameter of the fibres did not change with GO (reprinted from [260], with permission from Elsevier).
Materials 13 05083 g007
Figure 8. Photographs and cell viability (live cells in green and dead cells in red) of poly (lactic-co-glycolide) (PLG) scaffolds loaded with G manufactured by Direct Ink Writing (DIW). An increase in cell viability was produced when G was added (reprinted with permission from [268]. Copyright 2015 American Chemical Society).
Figure 8. Photographs and cell viability (live cells in green and dead cells in red) of poly (lactic-co-glycolide) (PLG) scaffolds loaded with G manufactured by Direct Ink Writing (DIW). An increase in cell viability was produced when G was added (reprinted with permission from [268]. Copyright 2015 American Chemical Society).
Materials 13 05083 g008
Figure 9. Preparation of poly(vinyl alcohol) (PVA)-GO powder for Selective Laser Sintering (SLS) printing: (a) SEM image of initial PVA powder; (b) TEM image of initial GO; (c) photographs of GO/PVA suspersion in deionized water after ultrasonication; (d,e) SEM images of the composite powder after evaporation of water [98].
Figure 9. Preparation of poly(vinyl alcohol) (PVA)-GO powder for Selective Laser Sintering (SLS) printing: (a) SEM image of initial PVA powder; (b) TEM image of initial GO; (c) photographs of GO/PVA suspersion in deionized water after ultrasonication; (d,e) SEM images of the composite powder after evaporation of water [98].
Materials 13 05083 g009
Figure 10. Polylactic acid (PLA)/PUA gyroid scaffolds manufactured by (a,b) Stereolithography (SLA) [238] and (c,d) Digital Light Processing (DLP) [240]. The addition of nanomaterials did not affect the printing process.
Figure 10. Polylactic acid (PLA)/PUA gyroid scaffolds manufactured by (a,b) Stereolithography (SLA) [238] and (c,d) Digital Light Processing (DLP) [240]. The addition of nanomaterials did not affect the printing process.
Materials 13 05083 g010
Figure 11. (A) Morphology of bone growth on CS/PCL scaffold with (G10) and without (G0) graphene manufactured by FDM. Images took by μ-CT. (B) Relative bone mass volume (BV/TV) at fixed-sized critical lesion ar different times. It is seen how the presence of G increased the bone growth rate (reprinted from [68], with permission from Elsevier).
Figure 11. (A) Morphology of bone growth on CS/PCL scaffold with (G10) and without (G0) graphene manufactured by FDM. Images took by μ-CT. (B) Relative bone mass volume (BV/TV) at fixed-sized critical lesion ar different times. It is seen how the presence of G increased the bone growth rate (reprinted from [68], with permission from Elsevier).
Materials 13 05083 g011
Figure 12. Ceramic parts printed by DIW with and without GO. (A) Images of scaffolds produced with GO added to the ink (reprinted from [70], with permission from Elsevier); (B) photographs of scaffolds produced (a) without nanomaterials, (b) with 0.25 wt.% and 0.75 wt.% of nanomaterials added by infiltration into the pores (reprinted from [69], with permission from Elsevier); (C) Tricalcium phosphate (TCP) disks without and with GO coating (reprinted from [54], with permission from Elsevier).
Figure 12. Ceramic parts printed by DIW with and without GO. (A) Images of scaffolds produced with GO added to the ink (reprinted from [70], with permission from Elsevier); (B) photographs of scaffolds produced (a) without nanomaterials, (b) with 0.25 wt.% and 0.75 wt.% of nanomaterials added by infiltration into the pores (reprinted from [69], with permission from Elsevier); (C) Tricalcium phosphate (TCP) disks without and with GO coating (reprinted from [54], with permission from Elsevier).
Materials 13 05083 g012
Figure 13. (a) SEM images of PCL/Hydroxyapatite (HA)/multiwalled carbon nanotube (MWCNT) scaffold fabricated using DIW. (b) Images with higher magnification. MWCNTs that were incorporated at a low level of loading were well-dispersed within the polymer matrix, which increased the mechanical properties (reprinted from [274], with permission from Elsevier).
Figure 13. (a) SEM images of PCL/Hydroxyapatite (HA)/multiwalled carbon nanotube (MWCNT) scaffold fabricated using DIW. (b) Images with higher magnification. MWCNTs that were incorporated at a low level of loading were well-dispersed within the polymer matrix, which increased the mechanical properties (reprinted from [274], with permission from Elsevier).
Materials 13 05083 g013
Figure 14. Images of Graphene-CaSiO3 porous scaffold fabricated using SLS (left) and variation in fracture toughness on addition of G (right). There was an optimal level of G loading in terms of fracture toughness due to the inability to disperse the G within the matrix [275].
Figure 14. Images of Graphene-CaSiO3 porous scaffold fabricated using SLS (left) and variation in fracture toughness on addition of G (right). There was an optimal level of G loading in terms of fracture toughness due to the inability to disperse the G within the matrix [275].
Materials 13 05083 g014
Table 1. Properties of carbon-based nanomaterials for bone tissue engineering applications.
Table 1. Properties of carbon-based nanomaterials for bone tissue engineering applications.
Bactericidal MechanismOsteoconductivityPossible ToxicityReferences
Carbon nanotubesBindingElectrochemical interactions with cells
Increase wettability
Biopersistent
Easy penetration in the cell membrane
Metal catalysts trapped
[132,133,157,158,159,160,161,162,163,164,165]
GraphenePhysical damageIncrease wettabilityAgglomeration on cell membranes
ROS generation
[93,134,143,144,160,166,167,168,169,170]
Graphene oxidePhysical damage
ROS generation
Increase wettabilityROS generation[134,135,171,172,173,174,175,176]
FullerenesBindingOnly after agingInduce DNA breakage
ROS generation
[151,152,177,178,179,180]
NanodiamondBindingIncrease wettabilityNo cytotoxicity
No ROS generation
[153,154,181,182,183,184]
Table 2. Comparison of technologies of additive manufacturing available for biodegradable materials with nanomaterials.
Table 2. Comparison of technologies of additive manufacturing available for biodegradable materials with nanomaterials.
FDMDIWSLSSLMSLADLP
MaterialThermoplastic polymerPolymer or polymer + ceramicPolymer or ceramicThermoplastic polymerPhotocurable polymerPhotocurable polymer
MorphologyFilamentInkPowderPowderLiquidLiquid
AccuracyLowMediumMediumLowHighHigh
Nanomaterial dispersionSolvent dissolution
Melt mixing by extrusion
Solvent mixing
Centrifuge mixing
Ultrasonication
Melt mixing by extrusion
Dissolution—precipitation
Physical mixing
Melt mixingSolvent mixing
Ultrasonication
Ultrasonication
AdvantagesSimplicity, speediness and large-scale production
Low cost
The most common AM technology
Flexible manufacturing
Low cost
Large parts manufacturing
High print speed
Good mechanical properties
Printing w/o support structures
Excellent mechanical properties
Improved density compared to SLS
Printing w/o support structures
Smooth surface finish
Excellent part quality
Excellent ability to fabricate complex structures
UV sterilisation
High accuracy
Excellent part quality
Excellent ability to fabricate complex structures
Higher print speed than SLA
UV sterilisation
LimitationsSupport structures required
Highly anisotropic parts
Nozzle clogging
Layer delamination
Sterilisation process may affect the material
Pore size limited by the low accuracy
Support structures required
Deposited ink should retain its shape
High temperature reached
Unmelted powders may be trapped
Extensive cleaning is needed after printing
Polymer powder production with adequate flowability
Expensive
High temperature reached
Unmelted powders may be trapped
Extensive cleaning is needed after printing
Polymer powder production with adequate flowability
Pore size limited by the low accuracy
Extensive post-treatments
Uncured resin toxicity
Support structures required
Resin cannot be storage indefinitely
Extensive post-treatments
Uncured resin toxicity
Support structures required
Resin cannot be storage indefinitely
Ref[218,225,226,227,228][218,229,230][218,231,232,233][218,234,235][218,236,237,238,239][218,240]
Table 3. Polymer scaffolds obtained by 3D printer with different carbon-based nanomaterials.
Table 3. Polymer scaffolds obtained by 3D printer with different carbon-based nanomaterials.
TechnologyNanomaterialNanomaterial DispersionMatrixEffect of Carbon-Based NanomaterialsRef.
FDMGO
(0.5 wt.%)
Solvent mixingTPU/PLAIncrease tensile and compression modulus
Low amount of GO increases cell proliferation
[65]
GO
(0.3 wt.%)
Solvent mixingPLAIncrease Young’s modulus
Increase toughness
More efficient promotion of cell adhesion and proliferation
[262]
GO
(7.5 wt.%/
0.5 wt.%)
Solvent mixingPCLImprove antimicrobial properties
Enhancement of cellular response
[260,261]
G
(0.78 wt.%)
Melt mixingPCLCell proliferation stimulation
Increase hydrophilicity
Increase compressive modulus and strength
[93,143,263]
G
(3 wt.%)
Solvent mixingPTMCIncrease electrical conductivity
Increase tensile strength, elongation at break and Young’s modulus
No effect on cell attachment and viability
[264]
GNP
(4 wt.%)
Melt mixingABSIncrease tensile modulus
Reduction in ultimate tensile stress and strain
Reduction in creep compliance
[227]
Carbon nanofibers/GNP
(18 wt.%)
Commercial filamentPLACNF reduces compression stiffness
Improve bioactivity
[265]
MWCNT
(3 wt.%)
Melt mixingPCLIncrease in compressive modulus and strength
Improve cell viability and proliferation
Increase polymer crystallinity
Increase hardness and elastic modulus
[263,266]
MWCNT/nHA
(0.75 wt.%)
Melt mixingPCLIncrease compressive strength
Improve cell attachment
[267]
DIWG
(20 vol.%)
Solvent mixingPLGIncrease tensile modulus
High loading decreases the tensile strength
Increase cell proliferation
[268]
SLSGO
(2.5 wt.%)
Ultrasonication of water dispersionPVAIncrease tensile strength, elongation at break, compressive modulus and compressive strength
Good cytocompatibility
[98]
GO
(1 wt.%)
Ultrasonication of water dispersionPEEK */
PVA
Increase surface energy
Increase compressive modulus and strength
Increase cell proliferation
[269]
GO
(1 wt.%)
Ultrasonication of solvent dispersionPLLAIncrease compressive strength
Increase hardness
[270]
GO/Ag
(1 wt.%)
Ultrasonication of solvent dispersion + ball millingPLLA/
PGA
Increase compressive strength and modulus
Increase wettability
Antibacterial effect
[271]
GO
(0.3 wt.%)
Ultrasonication of solvent dispersionPVDF *Increase compressive strength, tensile strength, and modulus
Increase hydrophilicity
Improve cellular response
[99]
ND/MoS2
(2 wt.%)
Ultrasonication of solvent dispersionPHBVIncrease tensile strength and modulus
Increase compressive strength and modulus
Enhanced mineral deposition
[272]
SLAG
(0.5 wt.%)
UltrasonicationPLA/
PUA
Increase tensile strength
Increase flexural strength and modulus
[238]
DLPGNP
(0.5 wt.%)
UltrasonicationPLA/
PUA
Increase flexural modulus and fracture toughness
No effect on printability
[240]
* Non-biodegradable.
Table 4. Ceramic-based 3D scaffolds fabricated by using additive manufacturing (AM) techniques with different carbon-based nanomaterials.
Table 4. Ceramic-based 3D scaffolds fabricated by using additive manufacturing (AM) techniques with different carbon-based nanomaterials.
TechnologyNanomaterialNanomaterial DispersionMatrixEffect of Carbon-Based NanomaterialRef.
FDMG
(10 wt.%)
Ultrasonication of solvent dispersionCalcium silicate/PCLIncrease hydrophilicity
Increase Young’s modulus
Increase compressive strength
Improve cellular response and bone regeneration
[68]
DIWGO
(50 wt./vol.%)
Coating prepared with water/GO suspension ultrasonically stirredβ-TCP/PVAEnhanced biological properties: cell proliferation, alkaline phosphatase activity and osteogenic gene expression[69]
GO
(0.5 wt.%)
Mechanical stirringTCP/AAImprove compressive and biological performance[174]
GO/rGO
(0.3 wt.%)
Mechanical stirringTCP/gelatin/chitosanBoth rGO and GO increase compressive strength and modulus. rGO has more effect.
GO improves calcium deposition
[70]
rGO/Mg
(50% wt./vol)
Filled into the pores of 3D printed scaffoldsβ-TCP/carboxymethylcellulose/sodium tripolyphosphateIncrease surface roughness
Increase Young’s modulus
Improve cell proliferation
Lower doses increase osteogenic differentiation
[54]
G
(21–24.5 vol.%)
Mixed by hand with solventHA/PLGACompared with HA, graphene reduces compressive modulus and increases strain to failure[273]
MWCNT
(0.75 wt.%)
Solvent mixingHA/PCLIncrease compressive strength for low content of CNT
Improve cell attachment
Increase electrical conductivity
Reduce compressive modulus
[274]
SLSG
(0.5 wt.%)
Ultrasonication of solvent dispersionNano-58S bioactive glassImprove compressive strength
Improve fracture toughness
[73]
G
(0.5 wt.%)
Ultrasonication of solvent dispersion + ball millingCalcium silicateImprove compressive strength
Improve fracture toughness
[275]
GNP
(1 wt.%)
Ultrasonication of solvent dispersionDiImprove compressive strength
Improve fracture toughness
[276]
MWCNT
(3 wt.%)
Ultrasonication of solvent dispersion + ball milling13–93 bioactive glassImprove compressive strength
Improve fracture toughness
[277]
MWCNT
(2 wt.%)
Ultrasonication of solvent dispersionDiImprove compressive strength
Improve fracture toughness
[278]
CNT
(0.2 wt.%)
Mechanical mixingβ-TCPImprove compressive strength[279]
CNT/GNP
(2 wt.%)
Ultrasonication of solvent dispersionDiSynergistic effect of nanomaterials
Increase compressive strength and modulus
Good cytocompatibility
[280]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lopez de Armentia, S.; del Real, J.C.; Paz, E.; Dunne, N. Advances in Biodegradable 3D Printed Scaffolds with Carbon-Based Nanomaterials for Bone Regeneration. Materials 2020, 13, 5083. https://doi.org/10.3390/ma13225083

AMA Style

Lopez de Armentia S, del Real JC, Paz E, Dunne N. Advances in Biodegradable 3D Printed Scaffolds with Carbon-Based Nanomaterials for Bone Regeneration. Materials. 2020; 13(22):5083. https://doi.org/10.3390/ma13225083

Chicago/Turabian Style

Lopez de Armentia, Sara, Juan Carlos del Real, Eva Paz, and Nicholas Dunne. 2020. "Advances in Biodegradable 3D Printed Scaffolds with Carbon-Based Nanomaterials for Bone Regeneration" Materials 13, no. 22: 5083. https://doi.org/10.3390/ma13225083

APA Style

Lopez de Armentia, S., del Real, J. C., Paz, E., & Dunne, N. (2020). Advances in Biodegradable 3D Printed Scaffolds with Carbon-Based Nanomaterials for Bone Regeneration. Materials, 13(22), 5083. https://doi.org/10.3390/ma13225083

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop